JPH0352477B2 - - Google Patents
Info
- Publication number
- JPH0352477B2 JPH0352477B2 JP57195419A JP19541982A JPH0352477B2 JP H0352477 B2 JPH0352477 B2 JP H0352477B2 JP 57195419 A JP57195419 A JP 57195419A JP 19541982 A JP19541982 A JP 19541982A JP H0352477 B2 JPH0352477 B2 JP H0352477B2
- Authority
- JP
- Japan
- Prior art keywords
- proline
- lysyl
- compounds
- phenylpropyl
- carboxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims description 48
- -1 4,5 dihydro-2-thiazolyl Chemical group 0.000 claims description 30
- 150000003839 salts Chemical class 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims description 4
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 7
- 108010064733 Angiotensins Proteins 0.000 description 7
- 102000015427 Angiotensins Human genes 0.000 description 7
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 7
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 238000004440 column chromatography Methods 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 108010016626 Dipeptides Proteins 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 239000007859 condensation product Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 229960002576 amiloride Drugs 0.000 description 4
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 4
- 239000002220 antihypertensive agent Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 239000002270 dispersing agent Substances 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 229960002003 hydrochlorothiazide Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- YKFCISHFRZHKHY-NGQGLHOPSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate Chemical compound O.O.O.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 YKFCISHFRZHKHY-NGQGLHOPSA-N 0.000 description 3
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 3
- 229940093817 Convertase inhibitor Drugs 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000019484 Rapeseed oil Nutrition 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229940030600 antihypertensive agent Drugs 0.000 description 3
- 239000007900 aqueous suspension Substances 0.000 description 3
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 229960004605 timolol Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- PRKWVSHZYDOZLP-UHFFFAOYSA-N 2-[(6,7-dichloro-2-methyl-1-oxo-2-phenyl-3h-inden-5-yl)oxy]acetic acid Chemical compound C1C2=CC(OCC(O)=O)=C(Cl)C(Cl)=C2C(=O)C1(C)C1=CC=CC=C1 PRKWVSHZYDOZLP-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 235000006491 Acacia senegal Nutrition 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 101800004538 Bradykinin Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 229960002155 chlorothiazide Drugs 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 229960003883 furosemide Drugs 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229950009607 indacrinone Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 229960003712 propranolol Drugs 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- FSKKYLRUHAXNEP-AWEZNQCLSA-N (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]-2-phenylmethoxycarbonylpentanoic acid Chemical compound [O-][N+](=O)NC(=N)NCCC[C@](N)(C(O)=O)C(=O)OCC1=CC=CC=C1 FSKKYLRUHAXNEP-AWEZNQCLSA-N 0.000 description 1
- VNFVKWMKVDOSKT-LREBCSMRSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;piperazine Chemical compound C1CNCCN1.OC(=O)[C@H](O)[C@@H](O)C(O)=O VNFVKWMKVDOSKT-LREBCSMRSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- ZUWFBQUHBOUPFK-UHFFFAOYSA-N 1-chloro-2-isothiocyanatoethane Chemical compound ClCCN=C=S ZUWFBQUHBOUPFK-UHFFFAOYSA-N 0.000 description 1
- WGMHMVLZFAJNOT-UHFFFAOYSA-N 1-ethoxyethylideneazanium;chloride Chemical compound [Cl-].CCOC(C)=[NH2+] WGMHMVLZFAJNOT-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- BSQLQMLFTHJVKS-UHFFFAOYSA-N 2-chloro-1,3-benzothiazole Chemical compound C1=CC=C2SC(Cl)=NC2=C1 BSQLQMLFTHJVKS-UHFFFAOYSA-N 0.000 description 1
- UNCQVRBWJWWJBF-UHFFFAOYSA-N 2-chloropyrimidine Chemical compound ClC1=NC=CC=N1 UNCQVRBWJWWJBF-UHFFFAOYSA-N 0.000 description 1
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 1
- QFGRBBWYHIYNIB-UHFFFAOYSA-N 2-methylsulfanyl-4,5-dihydro-1,3-thiazole Chemical compound CSC1=NCCS1 QFGRBBWYHIYNIB-UHFFFAOYSA-N 0.000 description 1
- 229940080296 2-naphthalenesulfonate Drugs 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241001351283 Arta Species 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- CVBMAZKKCSYWQR-BPJCFPRXSA-N Deserpidine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cccc3 CVBMAZKKCSYWQR-BPJCFPRXSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 208000004248 Familial Primary Pulmonary Hypertension Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 206010020571 Hyperaldosteronism Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- CESYKOGBSMNBPD-UHFFFAOYSA-N Methyclothiazide Chemical compound ClC1=C(S(N)(=O)=O)C=C2S(=O)(=O)N(C)C(CCl)NC2=C1 CESYKOGBSMNBPD-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- BDWCDXIYDXREMA-UWVGGRQHSA-N NCCCC[C@H](N(CC(O)=O)C(N)=N)C(=O)N1CCC[C@H]1C(O)=O Chemical class NCCCC[C@H](N(CC(O)=O)C(N)=N)C(=O)N1CCC[C@H]1C(O)=O BDWCDXIYDXREMA-UWVGGRQHSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- CYLWJCABXYDINA-UHFFFAOYSA-N Polythiazide Polymers ClC1=C(S(N)(=O)=O)C=C2S(=O)(=O)N(C)C(CSCC(F)(F)F)NC2=C1 CYLWJCABXYDINA-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 description 1
- 244000061121 Rauvolfia serpentina Species 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 208000027515 Tracheal disease Diseases 0.000 description 1
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004442 acylamino group Chemical class 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- PECIYKGSSMCNHN-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=NC=N[C]21.O=C1N(C)C(=O)N(C)C2=NC=N[C]21 PECIYKGSSMCNHN-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960002274 atenolol Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960003515 bendroflumethiazide Drugs 0.000 description 1
- HDWIHXWEUNVBIY-UHFFFAOYSA-N bendroflumethiazidum Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2CC1=CC=CC=C1 HDWIHXWEUNVBIY-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- NDTSRXAMMQDVSW-UHFFFAOYSA-N benzthiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1N=C2CSCC1=CC=CC=C1 NDTSRXAMMQDVSW-UHFFFAOYSA-N 0.000 description 1
- 229960001541 benzthiazide Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- JIVPVXMEBJLZRO-UHFFFAOYSA-N chlorthalidone Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C2(O)C3=CC=CC=C3C(=O)N2)=C1 JIVPVXMEBJLZRO-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- BALGDZWGNCXXES-UHFFFAOYSA-N cyclopentane;propanoic acid Chemical compound CCC(O)=O.C1CCCC1 BALGDZWGNCXXES-UHFFFAOYSA-N 0.000 description 1
- 229960003176 cyclothiazide Drugs 0.000 description 1
- BOCUKUHCLICSIY-QJWLJZLASA-N cyclothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2C1[C@H](C=C2)C[C@H]2C1 BOCUKUHCLICSIY-QJWLJZLASA-N 0.000 description 1
- ISMCNVNDWFIXLM-WCGOZPBSSA-N deserpidine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 ISMCNVNDWFIXLM-WCGOZPBSSA-N 0.000 description 1
- 229960001993 deserpidine Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960003199 etacrynic acid Drugs 0.000 description 1
- AVOLMBLBETYQHX-UHFFFAOYSA-N etacrynic acid Chemical compound CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl AVOLMBLBETYQHX-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- QSRVZCCJDKYRRF-YDALLXLXSA-N ethyl (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@@](C)(N)CC1=CC=C(O)C(O)=C1 QSRVZCCJDKYRRF-YDALLXLXSA-N 0.000 description 1
- JMIAPORGEDIDLT-UHFFFAOYSA-N ethyl ethanimidate Chemical compound CCOC(C)=N JMIAPORGEDIDLT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- ZUXNZUWOTSUBMN-UHFFFAOYSA-N hydralazine hydrochloride Chemical compound Cl.C1=CC=C2C(NN)=NN=CC2=C1 ZUXNZUWOTSUBMN-UHFFFAOYSA-N 0.000 description 1
- 229960005384 hydralazine hydrochloride Drugs 0.000 description 1
- BICAGYDGRXJYGD-UHFFFAOYSA-N hydrobromide;hydrochloride Chemical compound Cl.Br BICAGYDGRXJYGD-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960001823 methyldopate hydrochloride Drugs 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- AQCHWTWZEMGIFD-UHFFFAOYSA-N metolazone Chemical compound CC1NC2=CC(Cl)=C(S(N)(=O)=O)C=C2C(=O)N1C1=CC=CC=C1C AQCHWTWZEMGIFD-UHFFFAOYSA-N 0.000 description 1
- 229960002817 metolazone Drugs 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- BCXCABRDBBWWGY-UHFFFAOYSA-N n-benzyl-n-methylprop-2-yn-1-amine;hydrochloride Chemical compound Cl.C#CCN(C)CC1=CC=CC=C1 BCXCABRDBBWWGY-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229940042880 natural phospholipid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229960004239 pargyline hydrochloride Drugs 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229960005483 polythiazide Drugs 0.000 description 1
- 229920000046 polythiazide Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229960001289 prazosin Drugs 0.000 description 1
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
- 201000008312 primary pulmonary hypertension Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 208000037812 secondary pulmonary hypertension Diseases 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- CWCSCNSKBSCYCS-UHFFFAOYSA-M sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate Chemical compound [Na+].CCC(=C)C(=O)C1=CC=C(OCC([O-])=O)C(Cl)=C1Cl CWCSCNSKBSCYCS-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960004813 trichlormethiazide Drugs 0.000 description 1
- LMJSLTNSBFUCMU-UHFFFAOYSA-N trichlormethiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NC(C(Cl)Cl)NS2(=O)=O LMJSLTNSBFUCMU-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Description
æ¬çºæã¯ãã¢ã³ã®ãªãã³ã·ã³è»¢æé
µçŽ ã®æå¹
ãªé»å®³å€ã§ããæ°ããâã«ã«ããã·ã¡ãã«ïŒã¢
ããžãïŒãªãžã«âãããªã³ååç©ã«é¢ãããã®ã§
ãããåŸã€ãŠãããã®æ°èŠååç©ã¯ãè¬åŠçã«èš±
容ãããæ äœãšçµåãããã®çµæè¬åŠççµæç©ã
圢æããããŸããããã®æ°èŠååç©ã¯ãé«è¡å§æ²»
çã®äžæ¹æ³ã«ãããŠçšããããã ã¢ã³ã®ãªãã³ã·ã³ã¯ã匷åãªè¡ç®¡åçž®äœçšã
ãã€ãã«ã¢ã³æ§ããããã§ãããããã¯ã¢ã³ã®ãª
ãã³ã·ã³è»¢æé µçŽ ã®äœçšã«ãã€ãŠãäžæŽ»æ§ã®ã¢ã³
ã®ãªãã³ã·ã³ãã圢æããããè¿å¹Žãã¢ã³ã®ãª
ãã³ã·ã³è»¢æé µçŽ ã®åŒ·ãé»å®³å€ãå ±åãããŠãã
ãããããã¯ãé«è¡å§æ£è ã®è¡å§ãäœäžãããã
ãšãã§ãããæ¬çºæã§ããæ°èŠïŒ®âã«ã«ããã·ã¡
ãã«âïŒã¢ããžãïŒãªãžã«âãããªã³ååç©ãã
åæ§ã«ã¢ã³ã®ãªãã³ã·ã³è»¢æé µçŽ ã®åŒ·ãé»å®³å€ã§
ããã åè¡åœç¹èš±ç¬¬4113715å·ã第4129571å·åã³
4154960å·ã¯ã¢ããé žã®çœ®æã¢ã·ã«èªå°äœããã¢
ã³ã®ãªãã³ã·ã³è»¢æé µçŽ é»å®³å€ãšããŠæå¹ã§ãã
ããšãé瀺ããŠãããããã«ãããã®ååç©ã¯ã
èšåºäžæå¹ãªæé«è¡å§ååç©ã§ããã«ããããªã«
ããªãã¡ïŒ€âïŒâã¡ã«ã«ããâïŒâã¡ãã«ããã
ãã€ã«ââãããªã³ãå«ãã¡ã«ã«ãã眮æã¢ã·
ã«ã¢ããé žãšãã®èªå°äœã§ããã åäŸã®å è¡æè¡ååç©ã¯ãæ¬çºæã®ååç©ã§ã
ããžããããèªå°äœãšã¯ç°ãªããã®ã§ããããã
ã«åè¿°ã®æ¢ç¥ååç©ã¯ãæ¬è³ªçã«ã¹ã«ããããªã«
åºãããã¯ãã®èªå°äœãå«ãã§ããããæ¬çºæã®
ååç©ã¯ãããããå«ãã§ããªããããã«æ¬çºæ
ã®ãžããããååç©ã¯éåžžã®ãžãããããšã¯ç°ãª
ããâæ«ç«¯ã¯ã«ã«ããã·ã¡ãã«åºãšçµåããã
ã®ã«ã«ããã·ã¡ãã«åºã¯ãã¡ãã«åºãããã«çœ®æ
ãããååç©ã§ãããããã«ããã®ã«ã«ããã·ã«
åºã¯ãåæ§ã«ãšã¹ãã«ãã¢ããåã³å¡©ã®èªå°äœã«
å€æããããäºå®äžæ¬çºæã®ååç©ã¯ããããäº
ã€ã®éšåæ§é ã«åãããçªçŽ ååã«ãã€ãŠãαâ
ã¢ããé žããžããããã«èåããããšã«ãã€ãŠåœ¢
æãããæ··æååç©ïŒhybridsïŒã§ããããã®æ§
é çå€æã¯ãåæããããã倩ç¶ããããã®åé
ã«ãããŠåŸæ¥èŠãããªããã®ã§ãããäžèšäºã€ã®
å è¡æè¡ç¹èš±ã§è¿°ã¹ãŠããã¡ã«ã«ããã¢ã·ã«åã®
å®èœåºã«ãã€ãŠæ瀺ããããé瀺ããããã®ã§ã¯
ãªãã åè¡åœç¹èš±ç¬¬4052511å·ã¯ãâã«ã«ããã·ã¢
ã«ã«ãã€ã«âã¢ããé žãã¢ã³ã®ãªãã³ã·ã³è»¢æé µ
çŽ é»å®³å€ãšããŠæå¹ã§ããããšãé瀺ããŠããã
æ¬çºæã®ååç©ã¯ããžããããèªå°äœã§ããããš
ããã圢åŒçã«ãåè¡åœç¹èš±ç¬¬4052511å·ã«é瀺
ãããååç©ã®ããã€ãã«é¡äŒŒããŠãããšã¿ãªã
ãããããããªããããããªãããç¹ã«ã¡ãã¬ã³
åºã®äžã€ãæ¬çºæã§è¿°ã¹ãŠããã¢ããå®èœåºã«ã
ã€ãŠçœ®æãããå Žåã«ãé©ãã¹ãã»ã©é«ãå¯èœæ§
ã®ååç©ãåŸããããããšãã°ãæ¬çºæã§æ瀺ã
ããååç©ã¯ãç¹èš±ç¬¬4052511å·ã«é瀺ãããŠã
ãååç©ã®ãæäœæäžéã§ããïŒæ¥ãKgåœããïŒ
mgãããã¯æ£è ã®å¹³åäœéãçŽ150ãã³ããšãã
å Žåã«ãïŒæ¥æ£è äžäººåœãã60mgã«çžåœãããã«
察ããŠãïŒæ¥ãæ£è äžäººåœããçŽ2.5mgãšåçšåºŠ
äœãæäžéã§æäžããããšãã§ããã æãåºãç¯å²ã«ãããŠãæ¬çºæã¯ã次ã®æ§é
åŒïŒ
ãªé»å®³å€ã§ããæ°ããâã«ã«ããã·ã¡ãã«ïŒã¢
ããžãïŒãªãžã«âãããªã³ååç©ã«é¢ãããã®ã§
ãããåŸã€ãŠãããã®æ°èŠååç©ã¯ãè¬åŠçã«èš±
容ãããæ äœãšçµåãããã®çµæè¬åŠççµæç©ã
圢æããããŸããããã®æ°èŠååç©ã¯ãé«è¡å§æ²»
çã®äžæ¹æ³ã«ãããŠçšããããã ã¢ã³ã®ãªãã³ã·ã³ã¯ã匷åãªè¡ç®¡åçž®äœçšã
ãã€ãã«ã¢ã³æ§ããããã§ãããããã¯ã¢ã³ã®ãª
ãã³ã·ã³è»¢æé µçŽ ã®äœçšã«ãã€ãŠãäžæŽ»æ§ã®ã¢ã³
ã®ãªãã³ã·ã³ãã圢æããããè¿å¹Žãã¢ã³ã®ãª
ãã³ã·ã³è»¢æé µçŽ ã®åŒ·ãé»å®³å€ãå ±åãããŠãã
ãããããã¯ãé«è¡å§æ£è ã®è¡å§ãäœäžãããã
ãšãã§ãããæ¬çºæã§ããæ°èŠïŒ®âã«ã«ããã·ã¡
ãã«âïŒã¢ããžãïŒãªãžã«âãããªã³ååç©ãã
åæ§ã«ã¢ã³ã®ãªãã³ã·ã³è»¢æé µçŽ ã®åŒ·ãé»å®³å€ã§
ããã åè¡åœç¹èš±ç¬¬4113715å·ã第4129571å·åã³
4154960å·ã¯ã¢ããé žã®çœ®æã¢ã·ã«èªå°äœããã¢
ã³ã®ãªãã³ã·ã³è»¢æé µçŽ é»å®³å€ãšããŠæå¹ã§ãã
ããšãé瀺ããŠãããããã«ãããã®ååç©ã¯ã
èšåºäžæå¹ãªæé«è¡å§ååç©ã§ããã«ããããªã«
ããªãã¡ïŒ€âïŒâã¡ã«ã«ããâïŒâã¡ãã«ããã
ãã€ã«ââãããªã³ãå«ãã¡ã«ã«ãã眮æã¢ã·
ã«ã¢ããé žãšãã®èªå°äœã§ããã åäŸã®å è¡æè¡ååç©ã¯ãæ¬çºæã®ååç©ã§ã
ããžããããèªå°äœãšã¯ç°ãªããã®ã§ããããã
ã«åè¿°ã®æ¢ç¥ååç©ã¯ãæ¬è³ªçã«ã¹ã«ããããªã«
åºãããã¯ãã®èªå°äœãå«ãã§ããããæ¬çºæã®
ååç©ã¯ãããããå«ãã§ããªããããã«æ¬çºæ
ã®ãžããããååç©ã¯éåžžã®ãžãããããšã¯ç°ãª
ããâæ«ç«¯ã¯ã«ã«ããã·ã¡ãã«åºãšçµåããã
ã®ã«ã«ããã·ã¡ãã«åºã¯ãã¡ãã«åºãããã«çœ®æ
ãããååç©ã§ãããããã«ããã®ã«ã«ããã·ã«
åºã¯ãåæ§ã«ãšã¹ãã«ãã¢ããåã³å¡©ã®èªå°äœã«
å€æããããäºå®äžæ¬çºæã®ååç©ã¯ããããäº
ã€ã®éšåæ§é ã«åãããçªçŽ ååã«ãã€ãŠãαâ
ã¢ããé žããžããããã«èåããããšã«ãã€ãŠåœ¢
æãããæ··æååç©ïŒhybridsïŒã§ããããã®æ§
é çå€æã¯ãåæããããã倩ç¶ããããã®åé
ã«ãããŠåŸæ¥èŠãããªããã®ã§ãããäžèšäºã€ã®
å è¡æè¡ç¹èš±ã§è¿°ã¹ãŠããã¡ã«ã«ããã¢ã·ã«åã®
å®èœåºã«ãã€ãŠæ瀺ããããé瀺ããããã®ã§ã¯
ãªãã åè¡åœç¹èš±ç¬¬4052511å·ã¯ãâã«ã«ããã·ã¢
ã«ã«ãã€ã«âã¢ããé žãã¢ã³ã®ãªãã³ã·ã³è»¢æé µ
çŽ é»å®³å€ãšããŠæå¹ã§ããããšãé瀺ããŠããã
æ¬çºæã®ååç©ã¯ããžããããèªå°äœã§ããããš
ããã圢åŒçã«ãåè¡åœç¹èš±ç¬¬4052511å·ã«é瀺
ãããååç©ã®ããã€ãã«é¡äŒŒããŠãããšã¿ãªã
ãããããããªããããããªãããç¹ã«ã¡ãã¬ã³
åºã®äžã€ãæ¬çºæã§è¿°ã¹ãŠããã¢ããå®èœåºã«ã
ã€ãŠçœ®æãããå Žåã«ãé©ãã¹ãã»ã©é«ãå¯èœæ§
ã®ååç©ãåŸããããããšãã°ãæ¬çºæã§æ瀺ã
ããååç©ã¯ãç¹èš±ç¬¬4052511å·ã«é瀺ãããŠã
ãååç©ã®ãæäœæäžéã§ããïŒæ¥ãKgåœããïŒ
mgãããã¯æ£è ã®å¹³åäœéãçŽ150ãã³ããšãã
å Žåã«ãïŒæ¥æ£è äžäººåœãã60mgã«çžåœãããã«
察ããŠãïŒæ¥ãæ£è äžäººåœããçŽ2.5mgãšåçšåºŠ
äœãæäžéã§æäžããããšãã§ããã æãåºãç¯å²ã«ãããŠãæ¬çºæã¯ã次ã®æ§é
åŒïŒ
ãåŒãåã³
ãåŒäžã
ã¯æ°ŽçŽ ãR1ã¯ããšãã«äœçŽã¢ã«ãã«ãR2ã¯
âïŒCH2ïŒ4âNHâïŒïŒ§ã¯ïŒïŒïŒãžãããâïŒâ
ãã¢ãŸãªã«ãïŒâããªããžãã«ãïŒâãã³ãŸãã¢
ãŸãªã«ãïŒâã¢ããâ1HâïŒïŒïŒïŒïŒâããªã¢
ãŸãªâïŒâã€ã«ããŸãã¯
âïŒCH2ïŒ4âNHâïŒïŒ§ã¯ïŒïŒïŒãžãããâïŒâ
ãã¢ãŸãªã«ãïŒâããªããžãã«ãïŒâãã³ãŸãã¢
ãŸãªã«ãïŒâã¢ããâ1HâïŒïŒïŒïŒïŒâããªã¢
ãŸãªâïŒâã€ã«ããŸãã¯
ãåŒã
ïŒG1ã¯NHãŸãã¯ïŒ®âCNãG2ã¯NH2ãäœçŽã¢
ã«ãã«ã¢ãããŸãã¯äœçŽã¢ã«ãã«ïŒã
ã«ãã«ã¢ãããŸãã¯äœçŽã¢ã«ãã«ïŒã
ãåŒãã¯
ãåŒãã瀺ããã
ãããªãæ°èŠïŒ®âã«ã«ããã·ã¡ãã«ïŒã¢ããžãïŒ
âãªãžã«âãããªã³ååç©åã³è©²ååç©ã®è¬åŠç
ã«èš±å®¹ãããå¡©ã«é¢ããã äžèšãäœçŽã¢ã«ãã«çœ®æåºã¯ãä»ã«æèšããªã
ããããïŒããïŒåã®ççŽ ååããªãã¡ã¡ãã«ã
ãšãã«ãïœâãããã«ãïœâããã«ãïœâãã
ã«ãïœâããã«ãïœâãã³ãã«ãïœâãã³ãã«ã
ïœâããã·ã«ççŽéãåæéã®çåæ°ŽçŽ ã©ãžã«ã«
ãè¡šããã æ§é åŒã®ååç©ã¯ãç¡æ©é žãããã¯ææ©é žã
ãèªå°ãããå¡©ã圢æããéã«çšããããããã®
ãããªå¡©ã«å«ãŸãããã®ã¯ã次ã«ç€ºãåŠãã§ã
ãïŒã¢ã»ããŒããã¢ãžããŒããã¢ã«ã®ããŒããã¢
ã¹ãã«ããŒãããã³ãŸãšãŒãããã³ãŒã³ã¹ã«ãã
ãŒãããã¹ã«ããšãŒããããã¬ãŒããã·ãã¬ãŒ
ããã«ã³ãã¢ã¬ãŒããã«ã³ãã¢ã¹ã«ãããŒããã·
ã¯ããã³ã¿ã³ããããªããŒãããžã°ã«ã³ããŒãã
ããã·ã«ã¹ã«ããšãŒãããšã¿ã³ã¹ã«ãããŒããã
ãã¬ãŒããã°ã«ã³ããã¿ããšãŒããã°ãªã»ããã¹
ããšãŒããããã¹ã«ããšãŒããããã¿ããšãŒãã
ãããµããšãŒããå¡©é žå¡©èåæ°ŽçŽ é žå¡©ããšãŠåæ°Ž
çŽ é žå¡©ãïŒâãã€ãããã·ãšã¿ã³ã¹ã«ãããŒãã
ã©ã¯ããŒãããã¬ãšãŒããã¡ã¿ã³ã¹ã«ãããŒãã
ïŒâããã¿ã¬ã³ã¹ã«ãããŒãããã³ãããŒãããª
ãã¶ã¬ãŒãããã¢ãšãŒãããã¯ãããŒããããŒã¹
ã«ããšãŒããïŒâããšãã«ããããªããŒãããã¯
ã¬ãŒããããã¬ãŒããããããªããŒããã¹ã¯ã·ã
ãŒããã¿ãŒã¿ã¬ãŒããããªã·ã¢ããŒãããã·ã¬ãŒ
ãåã³ãŠã³ãã«ããšãŒããåæ§ã«ããã§ãã
å Žåã«ã¯ãç¡æ©å¡©åºåã³ææ©å¡©åºããèªå°ããã
å¡©ã圢æãããããã®ãããªå¡©ã«å«ãŸãããã®ãš
ããŠã¯ããããªãŠã å¡©ãã«ãªãŠã å¡©ãã«ã«ã·ãŠã
å¡©åã³ã¢ã³ã¢ããŠã å¡©ãããã æ¬çºæãç¹ã«å¥œé©ãªååç©ã¯ä»¥äžã®éãã§ã
ãã N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒïŒïŒâãžãããâïŒâãã¢ãŸ
ã€ã«ïŒââãªãžã«ââãããªã³ïŒ N2âãïŒâïŒïŒ³ïŒâãšããã·ã«ã«ããã«âïŒâã
ãšãã«ãããã«ãâN6âïŒïŒâããªããžãã«ïŒâ
âãªãžã«ââãããªã³ïŒ ãã®çºæã®ååç©ã¯ãã¢ã³ã®ãªãã³ã·ã³è»¢æé µ
çŽ ãé»å®³ããããæ ã«ãã«ããããã§ããã¢ã³ã®
ãªãã³ã·ã³ãã¢ã³ã®ãªãã³ã·ã³ã«å€æããã
ãšãé²å®³ãããã¢ã³ã®ãªãã³ã·ã³ã¯åŒ·åãªæå§
ïŒè¡å§å¢é²ïŒç©è³ªã§ãããåŸã€ãŠãè¡å§ãäœäžã
ããããšã¯ãé«è¡å§ããã¢ã³ã®ãªãã³ã·ã³ã«é¢
ä¿ãããç¹ã«åç©åã³äººéã«ãããŠããã®çåæ
ãé»å®³ããããšã«ãã€ãŠå¯èœãšãªããããã«è»¢æ
é µçŽ ã¯ãè¡ç®¡æ¡åŒµããããã§ãããã©ãžããã³ã
æžå°ããããåŸã€ãŠãã¢ã³ã®ãªãã³ã·ã³è»¢æé µçŽ
ã®é»å®³å€ã¯ãã©ãžããã³ã®å¹åã«ãã€ãŠããªãè¡
å§ãäœäžãåŸããšèãããããä»ã®èãåŸãæ©æ§
ãå«ããŠãã®ãããªçžå¯ŸçéèŠæ§ã¯ç«èšŒãããã¹
ãæ®ãããŠããããã¢ã³ã®ãªãã³ã·ã³è»¢æé µçŽ ã®
é»å®³å€ã¯ãçš®ã ã®åç©ã¢ãã«ã«ãããŠæå¹ãªæé«
è¡å§å€ã§ããããŸãèšåºçã«ãããšãã°è èè¡ç®¡
æ§ãæªæ§åã³å 倩æ§é«è¡å§ã®å€ãã®æ£è ã«ã€ããŠ
æå¹ã§ãããããšãã°ãã€ã»ããŽãªãŠã»ã¯ãã·ãŠ
ãã³ïŒD.W.CushmanïŒããBiochemistry16å·»ã
5484é ïŒ1977幎ïŒãåç §ããããã 転æé µçŽ é»å®³å€ã®è©äŸ¡ã¯ã€ã³ãããïŒin
vitroïŒã§ã®é µçŽ é»å®³åæã«ãã€ãŠå°ãããŠããã
ããšãã°ãäžã€ã®æå¹ãªæ¹æ³ã«ãã«ã«ããã³ãžã«
ãªãã·ããšãã«ã¢ã©ãã«ãã¹ããžãã«ãã€ã·ã³ã®
å æ°Žå解ã枬å®ãããŠããã¯ã€ã»ããã©ãŠã
ïŒY.PiquilloudïŒããšãŒã»ã¬ã€ã³ãã«ãïŒA.
ReinharzïŒåã³ãšã ã»ãã¹ïŒM.RothïŒã
Biochem.Biophys.Artaã206å·»ã136é ïŒ1970
幎ïŒãã®åæããããã€ã³ããïŒin vivoïŒã®ç³»
ã§ã®è©äŸ¡ã¯ããšãã°J.R.Weeksåã³J.A.Jonesã
Proc.Soc.Exp.Biol.Med.ã104å·»ã646é ïŒ1960
幎ïŒãã®ææ³ã«ãããã¢ã³ã®ãªãã³ã·ã³ãæäž
ããæ£åžžè¡å§ã®ã©ããã«ãããŠããããã¯ãS.
KoletskyããPro.Soc.Exp.Biol.Med.ã125å·»ã
96é ïŒ1960幎ïŒãã®æ¹æ³ã«ããé«ã¬ãã³ã©ããå®
éšã«ãããŠãªãããŠããã åŸã€ãŠãçºæã®ååç©ã¯ãé«è¡å§ã®æ²»çã«æå¹
ã§ããããããã¯ãŸããæ¥æ§åã³æ ¢æ§ã®ãã€è¡æ§
å¿èç ã®åŠæ¹ã«ãããŠãäºæ¬¡çé«ã¢ã«ãã¹ããã³
çãäžæ¬¡åã³äºæ¬¡çèºé«è¡å§çãè è衰匱åã³è
é«è¡å§çã®æ²»çã«ãããŠãããã«åé çã®åŠãæ°
管é害çã®åŠæ¹ã«ãããŠäŸ¡å€ãããã®ã§ããã 以äžè¿°ã¹ãæ§ãªç æ°ã«å¯ŸããŠãæ¬çºæã®ååç©
ãé©çšããããšã¯ããã®åéã«ç²Ÿéãã人ã ã«ãš
ã€ãŠæããã§ãããã æ¬çºæã«åŸã€ãŠãè¬åŠçã«èš±å®¹ãããæ äœåã³
æ§é åŒã®ååç©ã®ãæ²»çäžæå¹ãªéãå«ãè¬åŠ
ççµæç©ãèšãããŠããã åæ§ã«ãæ¬çºæã«åŸã€ãŠãæ§é åŒã®ååç©
ããæ²»çäžæå¹ãªéãæäžããå¿ èŠã®ããæ£è ã«
æäžããããšãå«ãé«è¡å§æ²»çã®äžæ¹æ³ãèšãã
ãŠããã é«è¡å§ãæ²»çãããã€äžè¿°ãããããã®èšåºç
æ¡ä»¶ã«æ²¿ã€ãŠæ¬çºæã®ååç©ã¯ãéåžžã®éæ¯æ§ã®
è¬åŠçã«èš±å®¹ãããæ äœãã¢ãžãŠãã³ãåã³å±è²
å€ãå«ãäžå®æäžåœ¢åŒå ã§ãçµå£çã«ãå±æç
ã«ãéçµå£çã«ãåžå ¥ã¹ãã¬ã€ã«ãã€ãŠãããã
ã¯çŽè žçã«æäžããããããã§èšãéçµå£çãš
ã¯ãç®äžæ³šå°ãéèå ãçèå ãè ¹å 泚å°ããã
ã¯æ³šå ¥æè¡ãå«ãã§ãããæ¬çºæã®ååç©ã¯ãã
ãã¿ãã©ããã銬ãç¬ãç«çã®ææž©åç©ã®æ²»çã«
å ããŠã人éã®æ²»çã«ãããŠãå¹æçã§ããã 掻æ§æåãå«ãè¬åŠç調åã¯ãããšãã°ãé
å€ããããŒããããŒã³ãžãæ°Žæ§ãããã¯æ²¹æ§æžæ¿
液ãåæ£ç²ãããã¯é¡ç²ãæµ®æ¿æ¶²ã硬ã»è»ã«ãã»
ã«ãã·ããããããã¯ãšãªããµãŒã®åŠããçµå£æ
äžã«é©ãã圢ã§ãããçµå£æäžã®ããã®çµæç©
ã¯ãè¬åŠççµæç©ã補é ããæ¢ç¥ã®çš®ã ã®æ¹æ³ã«
åŸã€ãŠãªãããããŸããã®ãããªçµæç©ã¯ãè¬åŠ
çã«åªé ã§çŸå³ãªè£œå€ãæäŸããããã«ãçå³
å€ãå³èŠå€ãçè²å€ãé²è å€çããéžã°ããäžã€
ãªãããã以äžã®è©Šå€ãå«ããã®ã§ãããé å€
ã¯ã補é ã®ããã«é©åœãªãéæ¯æ§ã®è¬åŠçã«èš±å®¹
ããã賊圢å€ãšã®æ··åç©ã®äžã«æŽ»æ§æåãå«ãã§
ããããããã®è³Šåœ¢å€ã¯ãããšãã°ãçé žã«ã«ã·
ãŠã ãçé žãããªãŠã ãã©ã¯ããŒã¹ããªã³é žã«ã«
ã·ãŠã ãããã¯ãªã³é žãããªãŠã ã®åŠãäžæŽ»æ§åž
éå€ïŒã³ãŒã³ã¹ã¿ãŒããããã¯ã¢ã«ã®ãã³é žã®åŠ
ãé¡ç²ååã³å解å€ïŒã§ãã·ãããŒã©ãã³ããã
ã¯ã¢ã«ã·ã¢ã®åŠãçµåå€ïŒåã³ã¹ãã¢ãªã³é žãã°
ãã·ãŠã ãã¹ãã¢ãªã³é žãããã¯ã¿ã«ã¯ã®åŠã最
æ»å€ã®åŠãã§ãããé å€ã¯ã³ãŒãã€ã³ã°ãããªã
ããããã¯èè žç®¡ç³»å ã§å解ãåžåããã®ãé ã
ããããã«æ¢ç¥ã®æ¹æ³ã«ãã€ãŠã³ãŒãã€ã³ã°ã
ããããã«ãã€ãŠé·æéå¹ãããæç¶ããããã
ãšãã°ã°ãªã»ãªã«ã¢ãã¹ãã¢ã¬ãŒããããã¯ã°ãª
ã»ãªã«ãžã¹ãã¢ã¬ãŒããããã¯ããããã¯ãã¯ã¹
ãšå ±ã«æ··ãããã®ãé 延ç©è³ªïŒtime delay
materialïŒãšããŠäœ¿çšãããã çµå£æäžçšã®åœ¢æ ã¯ã掻æ§æåãããšãã°çé ž
ã«ã«ã·ãŠã ããªã³é žã«ã«ã·ãŠã ãããã¯ã«ãªãªã³
ã®åŠãäžæŽ»æ§åºäœåžéå€ãšæ··åãã硬質ã®ãŒã©ã
ã³ã«ãã»ã«ãšããŠããããã¯ã掻æ§æåãæ°Žãã
ããã¯ãªããæ²¹ãããŒããæ²¹ãæµåãã©ãã€ã³ã
ãªãªãŒãæ²¹ã®åŠãæ²¹æ§åªäœãšæ··åããè»è³ªã®ãŒã©
ãã³ã«ãã»ã«ãšããŠç€ºãããã æ°Žæ§ããã ã液ã¯ããã補é ããããã«é©åœãª
賊圢å€ãšã®æ··åç©ã®äžã«ã掻æ§ç©è³ªãå«ãã§ã
ãããã®ãããªè³Šåœ¢å€ã¯ãããšãã°ãããªãŠã ã«
ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãã¡ãã«ã»ã«ããŒã¹ã
ãã€ãããã·ãããã«ã¡ãã«ã»ã«ããŒã¹ãã¢ã«ã®
ã³é žãããªãŠã ãããªããã«ãããªãã³ããã©ã¬
ã«ã³ãã¬ã ãã¢ã«ã·ã¢ã¬ã ã®åŠãããã ãå€ã§ã
ããåæ£å€ãããã¯æµžæœ€å€ãšããŠã®ãããšãã°ã¬
ã·ãã³ã®åŠã倩ç¶ã«ååšãããªã³è質ããããã¯
ããªãªãã·ãšãã¬ã³ã¹ãã¢ã¬ãŒãã®åŠãã¢ã«ã®ã¬
ã³ãªãã·ããšèèªé žãšã®çž®åçæç©ããããã¯ã
ãã¿ãã«ãšãã¬ã³ãªãã·ã»ã¿ããŒã«ã®åŠãé·éè
èªæã¢ã«ã³ãŒã«é¡ãšãšãã¬ã³ãªãã·ããšã®çž®åç
æç©ããããã¯ããªãªãã·ãšãã¬ã³ãœã«ãããŒã«
ã¢ããªã¬ã¢ãŒãã®åŠãèèªé žãšããã·ããŒã«ãã
èªå°ãããéšåãšã¹ãã«ãšãšãã¬ã³ãªãã·ããšã®
çž®åæçæç©ããããã¯ããªãªãã·ãšãã¬ã³ ãœ
ã«ãã¿ã³ ã¢ãâãªã¬ã¢ãŒãã®åŠãèèªé žãšãã
ã·ããŒã«ç¡æ°Žç©ããèªå°ãããéšåãšã¹ãã«ãšãš
ãã¬ã³ãªãã·ããšã®çž®åçæç©ã§ãããäžèšã®æ°Ž
æ§ããã ã液ã¯ããŸããããšãã°ãšãã«ãŸãã¯ïœ
âãããã«ïœâãã€ãããã· ãã³ãŸãšãŒãã®åŠ
ãä¿åæãçè²å€ãå³èŠå€ãåã³ã·ãšç³ããµãã«
ãªã³ã®åŠãçå³å€ã®äžã€ãªãããã以äžãå«ãã æ²¹æ§ããã ã液ã¯ã掻æ§æåããªããæ²¹ããªãª
ãŒãæ²¹ããŽãæ²¹ãããã¯ã³ã³ãããæ²¹ã®åŠãéè
æ²¹äžã§ããããã¯æµåãã©ãã€ã³ã®åŠãããã©ã«
ãªã€ã«äžã§ããã ãããããšã«ãã€ãŠåœ¢æãã
ããæ²¹æ§ããã ã液ã¯ãããšãã°å¯ããã硬質ã
ã©ãã€ã³ãããã¯ã»ãã«ã¢ã«ã³ãŒã«ã®åŠãæ¿åå€
ãå«ããäžè¿°ããïŒã·ãšç³ããµãã«ãªã³ã®åŠãïŒ
çå³å€åã³å³èŠå€ãçŸå³ãªçµå£å€ãã€ããããã«
å ããããããããã®çµæç©ã¯ã¢ã¹ã³ã«ãã³é žã®
åŠãé žåé²æ¢å€ãå ããããšã«ãã€ãŠä¿åãã
ãã æ°Žãå ããããšã§æ°Žæ§ããã ã液ã圢æããã®
ã«é©ããåæ£ç²åã³é¡ç²ã¯ãåæ£ãããã¯æµžæœ€
å€ãããã ãå€åã³äžã€ãªãããã以äžã®ä¿åæ
ãšã®æ··åç©ã®äžã®æŽ»æ§æåãå«ãã§ãããé©åœãª
åæ£ãããã¯æµžæœ€å€åã³ããã ãå€ã¯ãã§ã«äžè¿°
ãããã®ã瀺ããŠãããããã«ããšãã°çå³å€ã
å³èŠå€åã³çè²å€ã®åŠã賊圢å€ãå«ãŸããã ãã®çºæã®è¬åŠççµæç©ã¯ãæ°Žãšæ²¹ã®ä¹³æ¿æ¶²ã®
圢æã«ã€ããŠãå«ãŸããã油局ã¯ãªãªãŒãæ²¹ãã
ãã¯ãªããæ²¹ã®åŠãéèæ²¹ããããã¯ãæµåãã©
ãã€ã³ã®åŠãããã©ã«ãªã€ã«ãããã¯ãããã®æ··
åç©ã§ãããé©åœãªä¹³æ¿å€ãšããŠã¯ãããšãã°ã¢
ã«ã·ã¢ã¬ã ãããã¯ãã©ã¬ã«ã³ãã¬ã ã®åŠã倩ç¶
ã®ã¬ã ã§ãããããšãã°å€§è±ã¬ã·ãã³ã®åŠã倩ç¶
ã®ãªã³è質ã§ãããããšãã°ãœã«ãã¿ã³ã¢ãâãª
ã¬ã¢ãŒãã®åŠãããã·ããŒã«ç¡æ°Žç©ãšèèªé žãã
èªå°ããããšã¹ãã«åã³éšåãšã¹ãã«ã§ãããå
ã³ããšãã°ããªãªãã·ãšãã¬ã³ãœã«ãã¿ã³ã¢ãâ
ãªã¬ã¢ãŒãã®åŠããäžè¿°ããéšåãšã¹ãã«ãšãšã
ã¬ã³ãªãã·ããšã®çž®åç£ç©ã§ãããä¹³æ¿æ¶²ã«ã¯ã
çå³å€åã³å³èŠå€ãå«ãŸããã ã·ããããšãšãªããµãŒã¯ãããšãã°ã°ãªã»ããŒ
ã«ããœã«ãããŒã«ã·ãšç³ã®åŠãçå³å€ãšå ±ã«åœ¢æ
ãããããã®åœ¢æã«ã¯åæ§ã«ç·©åå€ãä¿åæãå³
èŠå€ãçè²å€ãå«ãŸããããã®è¬åŠççµæç©ã¯ã
ãšãã°æ®ºèããæ³šå ¥å¯èœãªæ°Žæ§ãããã¯æ²¹æ§ã®ã
ãã ã液ãšããŠã殺èããæ³šå ¥å¯èœãªè£œå€ã圢æ
ããéã«ãªãããããã®ããã ã液ã¯ããã§ã«äž
è¿°ããé©åœãªåæ£ãããã¯æµžæœ€å€åã³ããã ãå€
ãçšããæ¢ç¥ã®æ¹æ³ã«åŸã€ãŠåœ¢æãããã殺èã
ãæ³šå ¥å¯èœãªè£œå€ã¯ãããšãã°ïŒïŒïŒâãã¿ã³ãž
ãªãŒã«æº¶æ¶²ãšããŠããåŠããéæ¯æ§ã®éçµå£çã«
蚱容ãããåžéå€ãããã¯æº¶åªäžã®ã殺èãã泚
å ¥å¯èœãªæº¶æ¶²ãããã¯ããã ã液ã§ããã䜿çšã«
éã蚱容ãããå±è²å€åã³æº¶åªã¯ãæ°Žããªã³ã²ã«
溶液åã³ç匵é£å¡©æ°Žã§ããããã®ä»ã«æ®ºèããèŠ
å®ã®æ²¹ãæ £äŸçã«æº¶åªãããã¯ããã ã溶åªãšã
ãŠçšããããããã®ç®çã®ããã«åæçã¢ãâãŸ
ãã¯ãžã°ãªã»ãªããå«ããŠããã€ãã®æåãªèŠå®
ã®æ²¹ãçšãããããããã«ããªã¬ã€ã³é žã®æ§ãªè
èªé žãæ³šå ¥ç©ã®è£œé ã«äœ¿ãããã æ¬çºæã®ååç©ã¯ãè¬å€ã®çŽè žæäžã®ãã座è¬
ã®åœ¢ã§æäžãããããããã®èª¿åã¯åžžæž©ã§åºäœã§
ãããçŽè žæž©åºŠã§æ¶²ç¶ã«ãªãâããªãã¡çŽè žå ã§
溶解ããŠè¬ç©ã解æŸããæ§ãªé©åœãªéåºæ¿ç賊圢
å€ãšãè¬ç©ãšãæ··åããããšã«ãã€ãŠè£œé ããåŸ
ãããã®ãããªç©è³ªã¯ãã³ã³ã¢ãã¿ãŒåã³ããªãš
ãã¬ã³ã°ãªã³ãŒã«ã§ããã äžæ¥åœããäžæ£è ã«ã€ãäžåãããã¯æ°åã§ïŒ
mgãã500mgã®å€ã§ã®æäžéã¯ãäžè¿°ããç¶æ³
ïŒç æ°ãïŒãæ²»çããéã«æå¹ã§ãããæãŸãã
ã¯ïŒæ¥åœãã2.5mgãã100mgãæäžç¯å²ã§ãã
ãã æ äœãšçµåããåŸã«åäžã®æäžåœ¢æ ãçæãã
掻æ§æåã®éã¯ãæ²»çãããæ£è ãšãåã ã®æäž
æ§åŒã«åºãããŠäžå®ã§ã¯ãªãã ããããªãããåã ã®æ£è ã«å¯Ÿããæ£ç¢ºãªæäž
éã¯ããã§ã«èª¬æããç¹å®ã®ååç©ã®æŽ»æ§ã幎
什ãäœéãå šè¬çãªå¥åº·ç¶æ ãæ§ãèŠå®é£ãæäž
æéãæäžçµéãæåºé床ãè¬ç©çµååã³æ²»çã
è¡ãªã€ãŠããåã ã®ç æ°ã®éãçãå«ããå€ãã®
èŠçŽ ã«åºãããŠããã æ¬çºæã®ååç©ã¯ãä»ã®æé«è¡å§å€åã³ãŸãã¯
å©å°¿å€ãšçµã¿åãããŠæäžãããããšãå¯èœã§ã
ããããšãã°æ¬çºæã®ååç©ã¯ãã¢ãããªããã¢
ããããŒã«ããã³ãããã«ã¡ãã¢ãžããã¯ããã¿
ãªãã³ãã¯ãããã¢ãžããã¯ãããžã³ãã¯ãªãã
ãšããã³ã¢ã»ããŒãåã³ã¿ã³ããŒãããã»ã«ããž
ã³ããžã¢ãŸãªãã·ããã°ã¢ãããã³ã¹ã«ããšãŒ
ããããã©ã©ãžã³ãããã¯ããªãããããã¯ãã
ãã¢ãžããããããã«ãã«ã¡ãã¢ãžããã€ã³ãã¯
ãªãã³ãã¡ãã©ãŸã³ãã¡ãããããŒã«ã¿ãŒããŒ
ããã¡ãã«ã¯ãããã¢ãžããã¡ãã«ããŒããã¡ã
ã«ããŒããŒããããã¯ããªãããããã·ãžã«ãã
ãŒãžãªã³ãããã¯ããªããããªãã¢ãžãããã©ãŸ
ã·ã³ããããã©ãããŒã«ãã©ãŠãŠãªã«ãã€ã¢ã»ãµ
ãŒãã³ããïŒrauwolfia serpentinaïŒãã¬ã·ã³ã¢
ãã³ãã¬ã»ã«ãã³ããããªãŠã ããããã©ãã·
ããã¹ãããã©ã¯ãã³ããã¢ããŒã«ãããªã¯ãã
ã¡ãã¢ãžããããªã¡ããã¢ã³ã«ã³ã·ã¬ãŒãããã³
ãºãã¢ãžããããã¿ãŸã³ããã¯ãªãããšã³ãããª
ã¢ã³ãã¬ã³ãã¢ã»ãã¢ãŸãŒã«ã¢ãããã¢ãããã€
ãªã³ãã·ã¯ããã¢ãžãããšã¿ã¯ãªã³é žãããã»ã
ããã¡ã«ãšããã·ãªã³ããã«ã€ã³ããããªãŠã ãš
ã¿ã¯ãªããŒãã®åŠãååç©ããã®ä»äžèšååç©ã®
æ··åç©åã³çµã¿åãããšçµã¿åãããããšã§çšã
ãããã å žåçã«ããããã®çµã¿åããã§çšãããã
åã ã®æ¥åžžçæäžéã¯ãæå°èšåºæäžéã®çŽ1/5
ãããããããåäžã§çšããããå Žåã«ã¯ãã®å
åç©ã®æ倧æäžéãŸã§ã«éãããã ãããã®çµã¿åããã説æããããã«ãäžæ¥åœ
ãã2.5mgãã100mgã§æå¹ã§ããæ¬çºæã®æé«è¡
å§å€ã®äžã€ã¯ãäžæ¥åœãã0.5mgãã100mgã®ç¯å²
ã®å€ã§èšãããŠããäžæ¥åœããã®éã§æ¬¡ã«ç€ºãå
åç©ãšãå¹æçã«çµã¿åãããããšãã§ããïŒ ãããã¯ãããã¢ãžãïŒ10ã100mgïŒïŒã¯ããã
ã¢ãžãïŒ125ã2000mgïŒïŒã€ã³ãã¯ãªãã³ã®ãšãã³
ããªããŒãé©åœãªå²åãšãããã®ïŒ25ã150mgïŒïŒ
ãšã¿ã¯ãªã³é žïŒ15ã2000mgïŒïŒã¢ãããªãïŒïŒã
20mgïŒïŒããã»ããïŒïŒã80mgïŒïŒãããã©ãããŒ
ã«ïŒ20ã480mgïŒïŒãã¢ããŒã«ïŒïŒã60mgïŒïŒã¡ã
ã«ããŒãïŒ65ã2000mgïŒåã³ã¡ãã«ããŒãã®ãã
ãã€ã«ãªãã·ãšãã«ãšã¹ãã«ïŒ30ã1000mgïŒãã
ãã«ãäžã€ã®è¬å€ãçµã¿åãããããšãããªãã¡
ãããã¯ãããã¢ãžãïŒ10ã100mgïŒãšã¢ãããª
ãïŒïŒã20mgïŒãšæ¬çºæã®è»¢æé µçŽ é»å®³å€ïŒ0.5
ã100mgïŒïŒãããã¯ãããã¢ãžãïŒ10ã100mgïŒ
ãšãã¢ããŒã«ïŒïŒã60mgïŒãšæ¬çºæã®è»¢æé µçŽ é»
害å€ïŒ0.5ã100mgïŒïŒã€ã³ãã¯ãªã³ ãšãã³ããª
ããŒã®é©åœæ¯éïŒ25ã150mgïŒãšã¢ãããªãïŒïŒ
ã20mgïŒãšæ¬çºæã®è»¢æé µçŽ é»å®³å€ïŒ0.5ã100
mgïŒã®çµã¿åããã¯é«è¡å§æ£è ã«ãããè¡å§ã調
ç¯ããã®ã«å¹æçã§ããããã¡ããããããã®æ
äžéç¯å²ã¯äžæ¥åœããã®æäžéãåå²ããŠæäžã
ããã®ã«å¿ èŠãªäžåäœéã«åºãããŠé©çšãããã®
ã§ããããã§ã«äžè¿°ããæ§ã«ãæäžéã¯ç æ°ã®æ§
質ãšéããæ£è ã®äœéãèŠå®é£ççš®ã ã®èŠçŽ ã«åº
ãããŠç°ãªããã®ã§ããã å žåçã«ãããã®ïŒè¬å€ã®ïŒçµã¿åããã¯ä»¥äž
ã«è«ããããŠããæ§ãªè¬åŠççµæç©ãšããŠåœ¢æã
ãåŸãã æ§é åŒã®ååç©çŸ€ã®äžååç©ãŸãæ··åç©ãã
ãã¯ççåŠçã«èš±å®¹ãããå¡©ã®çŽ0.5mgãªãã100
mgã¯ãççåŠçã«èš±å®¹ãããåºç€å€ãæ äœã賊圢
å€ãçµåå€ãä¿åæãå®å®åå€ãå³èŠå€çãšå ±
ã«ããããã蚱容ãããè¬åŠçææ³ã§äœãããäž
åäœæäžåœ¢åŒã®äžã«èª¿åãããããããã®çµæç©
ãããã¯è£œå€äžã®æŽ»æ§ç©è³ªã®éã¯ããã§ã«èšãã
ãç¯å²ã§é©åœãªæäžéãåŸãããéã§ããã æ§é åŒã®ååç©ã¯ãããã«ä»¥äžè¿°ã¹ãäžã€ãª
ãããã以äžã®æ¹æ³ã«ãã€ãŠåæãããã ãã®åéã«ç²Ÿéãã人ã ã«ãšã€ãŠæãããªãã
ã«ãããã«ã以äžã®å®æœäŸã«èª¬æããããã«ãã¢
ãããã«ã«ããã·ãã¡ã«ã«ããçã®åå¿ã«é¢äžã
ãªãå®èœåºã¯ãçž®ååå¿ã«éããããããããã
ãååŠã§æšæºãšãããæ¹æ³ã«ãã€ãŠä¿è·ãããç¶
ããŠä¿è·åºãé€å»ããããšã«ãã€ãŠç®çãšããç
æç©ãåŸãã  è©Šè¬ (a)
âãªãžã«âãããªã³ååç©åã³è©²ååç©ã®è¬åŠç
ã«èš±å®¹ãããå¡©ã«é¢ããã äžèšãäœçŽã¢ã«ãã«çœ®æåºã¯ãä»ã«æèšããªã
ããããïŒããïŒåã®ççŽ ååããªãã¡ã¡ãã«ã
ãšãã«ãïœâãããã«ãïœâããã«ãïœâãã
ã«ãïœâããã«ãïœâãã³ãã«ãïœâãã³ãã«ã
ïœâããã·ã«ççŽéãåæéã®çåæ°ŽçŽ ã©ãžã«ã«
ãè¡šããã æ§é åŒã®ååç©ã¯ãç¡æ©é žãããã¯ææ©é žã
ãèªå°ãããå¡©ã圢æããéã«çšããããããã®
ãããªå¡©ã«å«ãŸãããã®ã¯ã次ã«ç€ºãåŠãã§ã
ãïŒã¢ã»ããŒããã¢ãžããŒããã¢ã«ã®ããŒããã¢
ã¹ãã«ããŒãããã³ãŸãšãŒãããã³ãŒã³ã¹ã«ãã
ãŒãããã¹ã«ããšãŒããããã¬ãŒããã·ãã¬ãŒ
ããã«ã³ãã¢ã¬ãŒããã«ã³ãã¢ã¹ã«ãããŒããã·
ã¯ããã³ã¿ã³ããããªããŒãããžã°ã«ã³ããŒãã
ããã·ã«ã¹ã«ããšãŒãããšã¿ã³ã¹ã«ãããŒããã
ãã¬ãŒããã°ã«ã³ããã¿ããšãŒããã°ãªã»ããã¹
ããšãŒããããã¹ã«ããšãŒããããã¿ããšãŒãã
ãããµããšãŒããå¡©é žå¡©èåæ°ŽçŽ é žå¡©ããšãŠåæ°Ž
çŽ é žå¡©ãïŒâãã€ãããã·ãšã¿ã³ã¹ã«ãããŒãã
ã©ã¯ããŒãããã¬ãšãŒããã¡ã¿ã³ã¹ã«ãããŒãã
ïŒâããã¿ã¬ã³ã¹ã«ãããŒãããã³ãããŒãããª
ãã¶ã¬ãŒãããã¢ãšãŒãããã¯ãããŒããããŒã¹
ã«ããšãŒããïŒâããšãã«ããããªããŒãããã¯
ã¬ãŒããããã¬ãŒããããããªããŒããã¹ã¯ã·ã
ãŒããã¿ãŒã¿ã¬ãŒããããªã·ã¢ããŒãããã·ã¬ãŒ
ãåã³ãŠã³ãã«ããšãŒããåæ§ã«ããã§ãã
å Žåã«ã¯ãç¡æ©å¡©åºåã³ææ©å¡©åºããèªå°ããã
å¡©ã圢æãããããã®ãããªå¡©ã«å«ãŸãããã®ãš
ããŠã¯ããããªãŠã å¡©ãã«ãªãŠã å¡©ãã«ã«ã·ãŠã
å¡©åã³ã¢ã³ã¢ããŠã å¡©ãããã æ¬çºæãç¹ã«å¥œé©ãªååç©ã¯ä»¥äžã®éãã§ã
ãã N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒïŒïŒâãžãããâïŒâãã¢ãŸ
ã€ã«ïŒââãªãžã«ââãããªã³ïŒ N2âãïŒâïŒïŒ³ïŒâãšããã·ã«ã«ããã«âïŒâã
ãšãã«ãããã«ãâN6âïŒïŒâããªããžãã«ïŒâ
âãªãžã«ââãããªã³ïŒ ãã®çºæã®ååç©ã¯ãã¢ã³ã®ãªãã³ã·ã³è»¢æé µ
çŽ ãé»å®³ããããæ ã«ãã«ããããã§ããã¢ã³ã®
ãªãã³ã·ã³ãã¢ã³ã®ãªãã³ã·ã³ã«å€æããã
ãšãé²å®³ãããã¢ã³ã®ãªãã³ã·ã³ã¯åŒ·åãªæå§
ïŒè¡å§å¢é²ïŒç©è³ªã§ãããåŸã€ãŠãè¡å§ãäœäžã
ããããšã¯ãé«è¡å§ããã¢ã³ã®ãªãã³ã·ã³ã«é¢
ä¿ãããç¹ã«åç©åã³äººéã«ãããŠããã®çåæ
ãé»å®³ããããšã«ãã€ãŠå¯èœãšãªããããã«è»¢æ
é µçŽ ã¯ãè¡ç®¡æ¡åŒµããããã§ãããã©ãžããã³ã
æžå°ããããåŸã€ãŠãã¢ã³ã®ãªãã³ã·ã³è»¢æé µçŽ
ã®é»å®³å€ã¯ãã©ãžããã³ã®å¹åã«ãã€ãŠããªãè¡
å§ãäœäžãåŸããšèãããããä»ã®èãåŸãæ©æ§
ãå«ããŠãã®ãããªçžå¯ŸçéèŠæ§ã¯ç«èšŒãããã¹
ãæ®ãããŠããããã¢ã³ã®ãªãã³ã·ã³è»¢æé µçŽ ã®
é»å®³å€ã¯ãçš®ã ã®åç©ã¢ãã«ã«ãããŠæå¹ãªæé«
è¡å§å€ã§ããããŸãèšåºçã«ãããšãã°è èè¡ç®¡
æ§ãæªæ§åã³å 倩æ§é«è¡å§ã®å€ãã®æ£è ã«ã€ããŠ
æå¹ã§ãããããšãã°ãã€ã»ããŽãªãŠã»ã¯ãã·ãŠ
ãã³ïŒD.W.CushmanïŒããBiochemistry16å·»ã
5484é ïŒ1977幎ïŒãåç §ããããã 転æé µçŽ é»å®³å€ã®è©äŸ¡ã¯ã€ã³ãããïŒin
vitroïŒã§ã®é µçŽ é»å®³åæã«ãã€ãŠå°ãããŠããã
ããšãã°ãäžã€ã®æå¹ãªæ¹æ³ã«ãã«ã«ããã³ãžã«
ãªãã·ããšãã«ã¢ã©ãã«ãã¹ããžãã«ãã€ã·ã³ã®
å æ°Žå解ã枬å®ãããŠããã¯ã€ã»ããã©ãŠã
ïŒY.PiquilloudïŒããšãŒã»ã¬ã€ã³ãã«ãïŒA.
ReinharzïŒåã³ãšã ã»ãã¹ïŒM.RothïŒã
Biochem.Biophys.Artaã206å·»ã136é ïŒ1970
幎ïŒãã®åæããããã€ã³ããïŒin vivoïŒã®ç³»
ã§ã®è©äŸ¡ã¯ããšãã°J.R.Weeksåã³J.A.Jonesã
Proc.Soc.Exp.Biol.Med.ã104å·»ã646é ïŒ1960
幎ïŒãã®ææ³ã«ãããã¢ã³ã®ãªãã³ã·ã³ãæäž
ããæ£åžžè¡å§ã®ã©ããã«ãããŠããããã¯ãS.
KoletskyããPro.Soc.Exp.Biol.Med.ã125å·»ã
96é ïŒ1960幎ïŒãã®æ¹æ³ã«ããé«ã¬ãã³ã©ããå®
éšã«ãããŠãªãããŠããã åŸã€ãŠãçºæã®ååç©ã¯ãé«è¡å§ã®æ²»çã«æå¹
ã§ããããããã¯ãŸããæ¥æ§åã³æ ¢æ§ã®ãã€è¡æ§
å¿èç ã®åŠæ¹ã«ãããŠãäºæ¬¡çé«ã¢ã«ãã¹ããã³
çãäžæ¬¡åã³äºæ¬¡çèºé«è¡å§çãè è衰匱åã³è
é«è¡å§çã®æ²»çã«ãããŠãããã«åé çã®åŠãæ°
管é害çã®åŠæ¹ã«ãããŠäŸ¡å€ãããã®ã§ããã 以äžè¿°ã¹ãæ§ãªç æ°ã«å¯ŸããŠãæ¬çºæã®ååç©
ãé©çšããããšã¯ããã®åéã«ç²Ÿéãã人ã ã«ãš
ã€ãŠæããã§ãããã æ¬çºæã«åŸã€ãŠãè¬åŠçã«èš±å®¹ãããæ äœåã³
æ§é åŒã®ååç©ã®ãæ²»çäžæå¹ãªéãå«ãè¬åŠ
ççµæç©ãèšãããŠããã åæ§ã«ãæ¬çºæã«åŸã€ãŠãæ§é åŒã®ååç©
ããæ²»çäžæå¹ãªéãæäžããå¿ èŠã®ããæ£è ã«
æäžããããšãå«ãé«è¡å§æ²»çã®äžæ¹æ³ãèšãã
ãŠããã é«è¡å§ãæ²»çãããã€äžè¿°ãããããã®èšåºç
æ¡ä»¶ã«æ²¿ã€ãŠæ¬çºæã®ååç©ã¯ãéåžžã®éæ¯æ§ã®
è¬åŠçã«èš±å®¹ãããæ äœãã¢ãžãŠãã³ãåã³å±è²
å€ãå«ãäžå®æäžåœ¢åŒå ã§ãçµå£çã«ãå±æç
ã«ãéçµå£çã«ãåžå ¥ã¹ãã¬ã€ã«ãã€ãŠãããã
ã¯çŽè žçã«æäžããããããã§èšãéçµå£çãš
ã¯ãç®äžæ³šå°ãéèå ãçèå ãè ¹å 泚å°ããã
ã¯æ³šå ¥æè¡ãå«ãã§ãããæ¬çºæã®ååç©ã¯ãã
ãã¿ãã©ããã銬ãç¬ãç«çã®ææž©åç©ã®æ²»çã«
å ããŠã人éã®æ²»çã«ãããŠãå¹æçã§ããã 掻æ§æåãå«ãè¬åŠç調åã¯ãããšãã°ãé
å€ããããŒããããŒã³ãžãæ°Žæ§ãããã¯æ²¹æ§æžæ¿
液ãåæ£ç²ãããã¯é¡ç²ãæµ®æ¿æ¶²ã硬ã»è»ã«ãã»
ã«ãã·ããããããã¯ãšãªããµãŒã®åŠããçµå£æ
äžã«é©ãã圢ã§ãããçµå£æäžã®ããã®çµæç©
ã¯ãè¬åŠççµæç©ã補é ããæ¢ç¥ã®çš®ã ã®æ¹æ³ã«
åŸã€ãŠãªãããããŸããã®ãããªçµæç©ã¯ãè¬åŠ
çã«åªé ã§çŸå³ãªè£œå€ãæäŸããããã«ãçå³
å€ãå³èŠå€ãçè²å€ãé²è å€çããéžã°ããäžã€
ãªãããã以äžã®è©Šå€ãå«ããã®ã§ãããé å€
ã¯ã補é ã®ããã«é©åœãªãéæ¯æ§ã®è¬åŠçã«èš±å®¹
ããã賊圢å€ãšã®æ··åç©ã®äžã«æŽ»æ§æåãå«ãã§
ããããããã®è³Šåœ¢å€ã¯ãããšãã°ãçé žã«ã«ã·
ãŠã ãçé žãããªãŠã ãã©ã¯ããŒã¹ããªã³é žã«ã«
ã·ãŠã ãããã¯ãªã³é žãããªãŠã ã®åŠãäžæŽ»æ§åž
éå€ïŒã³ãŒã³ã¹ã¿ãŒããããã¯ã¢ã«ã®ãã³é žã®åŠ
ãé¡ç²ååã³å解å€ïŒã§ãã·ãããŒã©ãã³ããã
ã¯ã¢ã«ã·ã¢ã®åŠãçµåå€ïŒåã³ã¹ãã¢ãªã³é žãã°
ãã·ãŠã ãã¹ãã¢ãªã³é žãããã¯ã¿ã«ã¯ã®åŠã最
æ»å€ã®åŠãã§ãããé å€ã¯ã³ãŒãã€ã³ã°ãããªã
ããããã¯èè žç®¡ç³»å ã§å解ãåžåããã®ãé ã
ããããã«æ¢ç¥ã®æ¹æ³ã«ãã€ãŠã³ãŒãã€ã³ã°ã
ããããã«ãã€ãŠé·æéå¹ãããæç¶ããããã
ãšãã°ã°ãªã»ãªã«ã¢ãã¹ãã¢ã¬ãŒããããã¯ã°ãª
ã»ãªã«ãžã¹ãã¢ã¬ãŒããããã¯ããããã¯ãã¯ã¹
ãšå ±ã«æ··ãããã®ãé 延ç©è³ªïŒtime delay
materialïŒãšããŠäœ¿çšãããã çµå£æäžçšã®åœ¢æ ã¯ã掻æ§æåãããšãã°çé ž
ã«ã«ã·ãŠã ããªã³é žã«ã«ã·ãŠã ãããã¯ã«ãªãªã³
ã®åŠãäžæŽ»æ§åºäœåžéå€ãšæ··åãã硬質ã®ãŒã©ã
ã³ã«ãã»ã«ãšããŠããããã¯ã掻æ§æåãæ°Žãã
ããã¯ãªããæ²¹ãããŒããæ²¹ãæµåãã©ãã€ã³ã
ãªãªãŒãæ²¹ã®åŠãæ²¹æ§åªäœãšæ··åããè»è³ªã®ãŒã©
ãã³ã«ãã»ã«ãšããŠç€ºãããã æ°Žæ§ããã ã液ã¯ããã補é ããããã«é©åœãª
賊圢å€ãšã®æ··åç©ã®äžã«ã掻æ§ç©è³ªãå«ãã§ã
ãããã®ãããªè³Šåœ¢å€ã¯ãããšãã°ãããªãŠã ã«
ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãã¡ãã«ã»ã«ããŒã¹ã
ãã€ãããã·ãããã«ã¡ãã«ã»ã«ããŒã¹ãã¢ã«ã®
ã³é žãããªãŠã ãããªããã«ãããªãã³ããã©ã¬
ã«ã³ãã¬ã ãã¢ã«ã·ã¢ã¬ã ã®åŠãããã ãå€ã§ã
ããåæ£å€ãããã¯æµžæœ€å€ãšããŠã®ãããšãã°ã¬
ã·ãã³ã®åŠã倩ç¶ã«ååšãããªã³è質ããããã¯
ããªãªãã·ãšãã¬ã³ã¹ãã¢ã¬ãŒãã®åŠãã¢ã«ã®ã¬
ã³ãªãã·ããšèèªé žãšã®çž®åçæç©ããããã¯ã
ãã¿ãã«ãšãã¬ã³ãªãã·ã»ã¿ããŒã«ã®åŠãé·éè
èªæã¢ã«ã³ãŒã«é¡ãšãšãã¬ã³ãªãã·ããšã®çž®åç
æç©ããããã¯ããªãªãã·ãšãã¬ã³ãœã«ãããŒã«
ã¢ããªã¬ã¢ãŒãã®åŠãèèªé žãšããã·ããŒã«ãã
èªå°ãããéšåãšã¹ãã«ãšãšãã¬ã³ãªãã·ããšã®
çž®åæçæç©ããããã¯ããªãªãã·ãšãã¬ã³ ãœ
ã«ãã¿ã³ ã¢ãâãªã¬ã¢ãŒãã®åŠãèèªé žãšãã
ã·ããŒã«ç¡æ°Žç©ããèªå°ãããéšåãšã¹ãã«ãšãš
ãã¬ã³ãªãã·ããšã®çž®åçæç©ã§ãããäžèšã®æ°Ž
æ§ããã ã液ã¯ããŸããããšãã°ãšãã«ãŸãã¯ïœ
âãããã«ïœâãã€ãããã· ãã³ãŸãšãŒãã®åŠ
ãä¿åæãçè²å€ãå³èŠå€ãåã³ã·ãšç³ããµãã«
ãªã³ã®åŠãçå³å€ã®äžã€ãªãããã以äžãå«ãã æ²¹æ§ããã ã液ã¯ã掻æ§æåããªããæ²¹ããªãª
ãŒãæ²¹ããŽãæ²¹ãããã¯ã³ã³ãããæ²¹ã®åŠãéè
æ²¹äžã§ããããã¯æµåãã©ãã€ã³ã®åŠãããã©ã«
ãªã€ã«äžã§ããã ãããããšã«ãã€ãŠåœ¢æãã
ããæ²¹æ§ããã ã液ã¯ãããšãã°å¯ããã硬質ã
ã©ãã€ã³ãããã¯ã»ãã«ã¢ã«ã³ãŒã«ã®åŠãæ¿åå€
ãå«ããäžè¿°ããïŒã·ãšç³ããµãã«ãªã³ã®åŠãïŒ
çå³å€åã³å³èŠå€ãçŸå³ãªçµå£å€ãã€ããããã«
å ããããããããã®çµæç©ã¯ã¢ã¹ã³ã«ãã³é žã®
åŠãé žåé²æ¢å€ãå ããããšã«ãã€ãŠä¿åãã
ãã æ°Žãå ããããšã§æ°Žæ§ããã ã液ã圢æããã®
ã«é©ããåæ£ç²åã³é¡ç²ã¯ãåæ£ãããã¯æµžæœ€
å€ãããã ãå€åã³äžã€ãªãããã以äžã®ä¿åæ
ãšã®æ··åç©ã®äžã®æŽ»æ§æåãå«ãã§ãããé©åœãª
åæ£ãããã¯æµžæœ€å€åã³ããã ãå€ã¯ãã§ã«äžè¿°
ãããã®ã瀺ããŠãããããã«ããšãã°çå³å€ã
å³èŠå€åã³çè²å€ã®åŠã賊圢å€ãå«ãŸããã ãã®çºæã®è¬åŠççµæç©ã¯ãæ°Žãšæ²¹ã®ä¹³æ¿æ¶²ã®
圢æã«ã€ããŠãå«ãŸããã油局ã¯ãªãªãŒãæ²¹ãã
ãã¯ãªããæ²¹ã®åŠãéèæ²¹ããããã¯ãæµåãã©
ãã€ã³ã®åŠãããã©ã«ãªã€ã«ãããã¯ãããã®æ··
åç©ã§ãããé©åœãªä¹³æ¿å€ãšããŠã¯ãããšãã°ã¢
ã«ã·ã¢ã¬ã ãããã¯ãã©ã¬ã«ã³ãã¬ã ã®åŠã倩ç¶
ã®ã¬ã ã§ãããããšãã°å€§è±ã¬ã·ãã³ã®åŠã倩ç¶
ã®ãªã³è質ã§ãããããšãã°ãœã«ãã¿ã³ã¢ãâãª
ã¬ã¢ãŒãã®åŠãããã·ããŒã«ç¡æ°Žç©ãšèèªé žãã
èªå°ããããšã¹ãã«åã³éšåãšã¹ãã«ã§ãããå
ã³ããšãã°ããªãªãã·ãšãã¬ã³ãœã«ãã¿ã³ã¢ãâ
ãªã¬ã¢ãŒãã®åŠããäžè¿°ããéšåãšã¹ãã«ãšãšã
ã¬ã³ãªãã·ããšã®çž®åç£ç©ã§ãããä¹³æ¿æ¶²ã«ã¯ã
çå³å€åã³å³èŠå€ãå«ãŸããã ã·ããããšãšãªããµãŒã¯ãããšãã°ã°ãªã»ããŒ
ã«ããœã«ãããŒã«ã·ãšç³ã®åŠãçå³å€ãšå ±ã«åœ¢æ
ãããããã®åœ¢æã«ã¯åæ§ã«ç·©åå€ãä¿åæãå³
èŠå€ãçè²å€ãå«ãŸããããã®è¬åŠççµæç©ã¯ã
ãšãã°æ®ºèããæ³šå ¥å¯èœãªæ°Žæ§ãããã¯æ²¹æ§ã®ã
ãã ã液ãšããŠã殺èããæ³šå ¥å¯èœãªè£œå€ã圢æ
ããéã«ãªãããããã®ããã ã液ã¯ããã§ã«äž
è¿°ããé©åœãªåæ£ãããã¯æµžæœ€å€åã³ããã ãå€
ãçšããæ¢ç¥ã®æ¹æ³ã«åŸã€ãŠåœ¢æãããã殺èã
ãæ³šå ¥å¯èœãªè£œå€ã¯ãããšãã°ïŒïŒïŒâãã¿ã³ãž
ãªãŒã«æº¶æ¶²ãšããŠããåŠããéæ¯æ§ã®éçµå£çã«
蚱容ãããåžéå€ãããã¯æº¶åªäžã®ã殺èãã泚
å ¥å¯èœãªæº¶æ¶²ãããã¯ããã ã液ã§ããã䜿çšã«
éã蚱容ãããå±è²å€åã³æº¶åªã¯ãæ°Žããªã³ã²ã«
溶液åã³ç匵é£å¡©æ°Žã§ããããã®ä»ã«æ®ºèããèŠ
å®ã®æ²¹ãæ £äŸçã«æº¶åªãããã¯ããã ã溶åªãšã
ãŠçšããããããã®ç®çã®ããã«åæçã¢ãâãŸ
ãã¯ãžã°ãªã»ãªããå«ããŠããã€ãã®æåãªèŠå®
ã®æ²¹ãçšãããããããã«ããªã¬ã€ã³é žã®æ§ãªè
èªé žãæ³šå ¥ç©ã®è£œé ã«äœ¿ãããã æ¬çºæã®ååç©ã¯ãè¬å€ã®çŽè žæäžã®ãã座è¬
ã®åœ¢ã§æäžãããããããã®èª¿åã¯åžžæž©ã§åºäœã§
ãããçŽè žæž©åºŠã§æ¶²ç¶ã«ãªãâããªãã¡çŽè žå ã§
溶解ããŠè¬ç©ã解æŸããæ§ãªé©åœãªéåºæ¿ç賊圢
å€ãšãè¬ç©ãšãæ··åããããšã«ãã€ãŠè£œé ããåŸ
ãããã®ãããªç©è³ªã¯ãã³ã³ã¢ãã¿ãŒåã³ããªãš
ãã¬ã³ã°ãªã³ãŒã«ã§ããã äžæ¥åœããäžæ£è ã«ã€ãäžåãããã¯æ°åã§ïŒ
mgãã500mgã®å€ã§ã®æäžéã¯ãäžè¿°ããç¶æ³
ïŒç æ°ãïŒãæ²»çããéã«æå¹ã§ãããæãŸãã
ã¯ïŒæ¥åœãã2.5mgãã100mgãæäžç¯å²ã§ãã
ãã æ äœãšçµåããåŸã«åäžã®æäžåœ¢æ ãçæãã
掻æ§æåã®éã¯ãæ²»çãããæ£è ãšãåã ã®æäž
æ§åŒã«åºãããŠäžå®ã§ã¯ãªãã ããããªãããåã ã®æ£è ã«å¯Ÿããæ£ç¢ºãªæäž
éã¯ããã§ã«èª¬æããç¹å®ã®ååç©ã®æŽ»æ§ã幎
什ãäœéãå šè¬çãªå¥åº·ç¶æ ãæ§ãèŠå®é£ãæäž
æéãæäžçµéãæåºé床ãè¬ç©çµååã³æ²»çã
è¡ãªã€ãŠããåã ã®ç æ°ã®éãçãå«ããå€ãã®
èŠçŽ ã«åºãããŠããã æ¬çºæã®ååç©ã¯ãä»ã®æé«è¡å§å€åã³ãŸãã¯
å©å°¿å€ãšçµã¿åãããŠæäžãããããšãå¯èœã§ã
ããããšãã°æ¬çºæã®ååç©ã¯ãã¢ãããªããã¢
ããããŒã«ããã³ãããã«ã¡ãã¢ãžããã¯ããã¿
ãªãã³ãã¯ãããã¢ãžããã¯ãããžã³ãã¯ãªãã
ãšããã³ã¢ã»ããŒãåã³ã¿ã³ããŒãããã»ã«ããž
ã³ããžã¢ãŸãªãã·ããã°ã¢ãããã³ã¹ã«ããšãŒ
ããããã©ã©ãžã³ãããã¯ããªãããããã¯ãã
ãã¢ãžããããããã«ãã«ã¡ãã¢ãžããã€ã³ãã¯
ãªãã³ãã¡ãã©ãŸã³ãã¡ãããããŒã«ã¿ãŒããŒ
ããã¡ãã«ã¯ãããã¢ãžããã¡ãã«ããŒããã¡ã
ã«ããŒããŒããããã¯ããªãããããã·ãžã«ãã
ãŒãžãªã³ãããã¯ããªããããªãã¢ãžãããã©ãŸ
ã·ã³ããããã©ãããŒã«ãã©ãŠãŠãªã«ãã€ã¢ã»ãµ
ãŒãã³ããïŒrauwolfia serpentinaïŒãã¬ã·ã³ã¢
ãã³ãã¬ã»ã«ãã³ããããªãŠã ããããã©ãã·
ããã¹ãããã©ã¯ãã³ããã¢ããŒã«ãããªã¯ãã
ã¡ãã¢ãžããããªã¡ããã¢ã³ã«ã³ã·ã¬ãŒãããã³
ãºãã¢ãžããããã¿ãŸã³ããã¯ãªãããšã³ãããª
ã¢ã³ãã¬ã³ãã¢ã»ãã¢ãŸãŒã«ã¢ãããã¢ãããã€
ãªã³ãã·ã¯ããã¢ãžãããšã¿ã¯ãªã³é žãããã»ã
ããã¡ã«ãšããã·ãªã³ããã«ã€ã³ããããªãŠã ãš
ã¿ã¯ãªããŒãã®åŠãååç©ããã®ä»äžèšååç©ã®
æ··åç©åã³çµã¿åãããšçµã¿åãããããšã§çšã
ãããã å žåçã«ããããã®çµã¿åããã§çšãããã
åã ã®æ¥åžžçæäžéã¯ãæå°èšåºæäžéã®çŽ1/5
ãããããããåäžã§çšããããå Žåã«ã¯ãã®å
åç©ã®æ倧æäžéãŸã§ã«éãããã ãããã®çµã¿åããã説æããããã«ãäžæ¥åœ
ãã2.5mgãã100mgã§æå¹ã§ããæ¬çºæã®æé«è¡
å§å€ã®äžã€ã¯ãäžæ¥åœãã0.5mgãã100mgã®ç¯å²
ã®å€ã§èšãããŠããäžæ¥åœããã®éã§æ¬¡ã«ç€ºãå
åç©ãšãå¹æçã«çµã¿åãããããšãã§ããïŒ ãããã¯ãããã¢ãžãïŒ10ã100mgïŒïŒã¯ããã
ã¢ãžãïŒ125ã2000mgïŒïŒã€ã³ãã¯ãªãã³ã®ãšãã³
ããªããŒãé©åœãªå²åãšãããã®ïŒ25ã150mgïŒïŒ
ãšã¿ã¯ãªã³é žïŒ15ã2000mgïŒïŒã¢ãããªãïŒïŒã
20mgïŒïŒããã»ããïŒïŒã80mgïŒïŒãããã©ãããŒ
ã«ïŒ20ã480mgïŒïŒãã¢ããŒã«ïŒïŒã60mgïŒïŒã¡ã
ã«ããŒãïŒ65ã2000mgïŒåã³ã¡ãã«ããŒãã®ãã
ãã€ã«ãªãã·ãšãã«ãšã¹ãã«ïŒ30ã1000mgïŒãã
ãã«ãäžã€ã®è¬å€ãçµã¿åãããããšãããªãã¡
ãããã¯ãããã¢ãžãïŒ10ã100mgïŒãšã¢ãããª
ãïŒïŒã20mgïŒãšæ¬çºæã®è»¢æé µçŽ é»å®³å€ïŒ0.5
ã100mgïŒïŒãããã¯ãããã¢ãžãïŒ10ã100mgïŒ
ãšãã¢ããŒã«ïŒïŒã60mgïŒãšæ¬çºæã®è»¢æé µçŽ é»
害å€ïŒ0.5ã100mgïŒïŒã€ã³ãã¯ãªã³ ãšãã³ããª
ããŒã®é©åœæ¯éïŒ25ã150mgïŒãšã¢ãããªãïŒïŒ
ã20mgïŒãšæ¬çºæã®è»¢æé µçŽ é»å®³å€ïŒ0.5ã100
mgïŒã®çµã¿åããã¯é«è¡å§æ£è ã«ãããè¡å§ã調
ç¯ããã®ã«å¹æçã§ããããã¡ããããããã®æ
äžéç¯å²ã¯äžæ¥åœããã®æäžéãåå²ããŠæäžã
ããã®ã«å¿ èŠãªäžåäœéã«åºãããŠé©çšãããã®
ã§ããããã§ã«äžè¿°ããæ§ã«ãæäžéã¯ç æ°ã®æ§
質ãšéããæ£è ã®äœéãèŠå®é£ççš®ã ã®èŠçŽ ã«åº
ãããŠç°ãªããã®ã§ããã å žåçã«ãããã®ïŒè¬å€ã®ïŒçµã¿åããã¯ä»¥äž
ã«è«ããããŠããæ§ãªè¬åŠççµæç©ãšããŠåœ¢æã
ãåŸãã æ§é åŒã®ååç©çŸ€ã®äžååç©ãŸãæ··åç©ãã
ãã¯ççåŠçã«èš±å®¹ãããå¡©ã®çŽ0.5mgãªãã100
mgã¯ãççåŠçã«èš±å®¹ãããåºç€å€ãæ äœã賊圢
å€ãçµåå€ãä¿åæãå®å®åå€ãå³èŠå€çãšå ±
ã«ããããã蚱容ãããè¬åŠçææ³ã§äœãããäž
åäœæäžåœ¢åŒã®äžã«èª¿åãããããããã®çµæç©
ãããã¯è£œå€äžã®æŽ»æ§ç©è³ªã®éã¯ããã§ã«èšãã
ãç¯å²ã§é©åœãªæäžéãåŸãããéã§ããã æ§é åŒã®ååç©ã¯ãããã«ä»¥äžè¿°ã¹ãäžã€ãª
ãããã以äžã®æ¹æ³ã«ãã€ãŠåæãããã ãã®åéã«ç²Ÿéãã人ã ã«ãšã€ãŠæãããªãã
ã«ãããã«ã以äžã®å®æœäŸã«èª¬æããããã«ãã¢
ãããã«ã«ããã·ãã¡ã«ã«ããçã®åå¿ã«é¢äžã
ãªãå®èœåºã¯ãçž®ååå¿ã«éããããããããã
ãååŠã§æšæºãšãããæ¹æ³ã«ãã€ãŠä¿è·ãããç¶
ããŠä¿è·åºãé€å»ããããšã«ãã€ãŠç®çãšããç
æç©ãåŸãã  è©Šè¬ (a)
ãåŒããšããŠïŒ§ãåŸãããã«
ïŒåŒäžïŒ¬ã¯ãã¡ããã·ãã¡ãã«ããªããã«ãª
ããã¯ããçã®è±é¢åºã§ãããïŒ äŸïŒ (b)
ããã¯ããçã®è±é¢åºã§ãããïŒ äŸïŒ (b)
ãåŒããšããŠïŒ§ãåŸãããã«
(c) ïŒãŸãã¯ïŒå¡ã®è€çŽ ç°ããŸãã¯ãã®ãã³ãŸçž®
åè€çŽ ç°ãšããŠïŒ§ãåŸããã㫠âââ äŸïŒ ïŒïœã¯ïŒãŸãã¯ïŒïŒ äžè¿°ããåå¿ã®äžã§ãæ§é åŒã®åºçºç©è³ªã¯ã
èªå°äœè©Šè¬ãšçž®åããç®çãšããçæç©ãåŸãã
ãããã®è©Šè¬ã¯ããã®åéã«ç²Ÿéãã人ã ã«ãšã€
ãŠèŠãªãããã®ã§ãããåŸè¿°ããå®æœäŸäžãšåæ§
ã«äžèšã«è¡šããããã®ã§ããã 欧å·å ¬éç¹èš±ç¬¬0012401å·ã§èšè¿°ãããŠããå®
éšæ¹æ³ã«åŸã€ãŠåæãããåºçºç©è³ªããé©åœãªæº¶
åªäžã§æº¶è§£ããç®çãšããè©Šè¬ã®ïŒåœéããè¥å¹²
éå°éããã€ãããšå ãããã®åå¿æ··åç©ãæ°æ
éãã ããã«éæµãããããã§äœ¿ãããåºçºç©è³ª
ã¯ãïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³åã³N2â
ãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ãããã«ã
ââãªã«ããã«ââãããªã³ã§ãããããã
ã¯ã欧å·å ¬éç¹èš±ç¬¬0012401å·ã®å®æœäŸ57åã³116
ã«åŸã€ãŠåæãããã
åè€çŽ ç°ãšããŠïŒ§ãåŸããã㫠âââ äŸïŒ ïŒïœã¯ïŒãŸãã¯ïŒïŒ äžè¿°ããåå¿ã®äžã§ãæ§é åŒã®åºçºç©è³ªã¯ã
èªå°äœè©Šè¬ãšçž®åããç®çãšããçæç©ãåŸãã
ãããã®è©Šè¬ã¯ããã®åéã«ç²Ÿéãã人ã ã«ãšã€
ãŠèŠãªãããã®ã§ãããåŸè¿°ããå®æœäŸäžãšåæ§
ã«äžèšã«è¡šããããã®ã§ããã 欧å·å ¬éç¹èš±ç¬¬0012401å·ã§èšè¿°ãããŠããå®
éšæ¹æ³ã«åŸã€ãŠåæãããåºçºç©è³ªããé©åœãªæº¶
åªäžã§æº¶è§£ããç®çãšããè©Šè¬ã®ïŒåœéããè¥å¹²
éå°éããã€ãããšå ãããã®åå¿æ··åç©ãæ°æ
éãã ããã«éæµãããããã§äœ¿ãããåºçºç©è³ª
ã¯ãïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³åã³N2â
ãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ãããã«ã
ââãªã«ããã«ââãããªã³ã§ãããããã
ã¯ã欧å·å ¬éç¹èš±ç¬¬0012401å·ã®å®æœäŸ57åã³116
ã«åŸã€ãŠåæãããã
ãåŒã
åŒã®ååç©ã«é¢ããŠããããã®åæã¯ã以äž
ã«èšãåå¿å³ã«åŸã€ãŠéæãããã  åè¿°ããåå¿ã§çšããããè©Šè¬ã¯ãããšãã°ã
ã³ãŸã€ã«ã¯ããªããã·ã¢ãã²ã³ãããããã¡ãã«
ã€ãœã·ã¢ããŒãåã³ãã³ãŒã³ã¹ã«ããã«ã¯ããªã
ãå«ãã§ãããèªå°äœåæåå¿ã¯äž»ãšããŠããªãš
ãã«ã¢ãã³ã®åŠãéãããã³æ§å¡©åºã®ååšäž
DMFã®åŠãäžæŽ»æ§æº¶åªäžã§è¡ãªããããä»ã®å
å¿æ¡ä»¶ã¯ä»¥äžã«èšãããŠããå®éšäŸã®äžã§èšèŒã
ããŠããã ããã§äœ¿ãããåºçºç©è³ªã¯ãN2âãïŒâïŒïŒ³ïŒâ
ã«ã«ããã·âïŒâããšãã«ãããã«ãââã¢ã«
ã®ãã«ââãããªã³ã§ãããããã¯æ¬§å·å ¬éç¹
蚱第0012401å·ã®å®æœäŸ121ã«åŸã€ãŠåæãããã
ãŸããåæçµéã®å šäœãéããŠãã¢ããé žã®èªå°
äœãå©çšããããšã«ãã€ãŠãæ¬çºæã®ååç©çŸ€ã®
ããã€ããåæããããšãå¯èœã§ãããããšã
ã°ãαâã«ã«ããã³ãžã«ãªãã·âÏâãããã¢ã«
ã®ãã³ããããçš®ã®ã¢ããé žãšã¹ãã«ãšçž®åãã
ç¶ããŠéå çã«ïŒâãªããã¢ã«ã«ãã³é žãšã¢ã«ã
ã«åããä¿è·åºãé€å»ãããšãæ§é åŒã®G1ã
ïŒNNO2ã®ååç©ãåŸãããšãã§ããã ç¶ãå®æœäŸã§ã¯ãããã«ãæ§é åŒã®ååç©ã
åæããã®ã«çšããããè©Šè¬ãšåæçµè·¯ãèšãã
ãŠããããããã¯æ¬çºæã®å žåçãªâå¶éçãªã
ã®ã§ã¯ãâå®æœäŸãšãªããã®ã§ããã å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒïŒïŒâãžãããâïŒâãã¢
ãŸã€ã«ïŒââãªãžã«ââãããªã³ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³ïŒ406mgãïŒ
mmolïŒãã¡ã¿ããŒã«10mlãšæ°ŽïŒmläžã«æº¶è§£ããã
ãã®æº¶æ¶²ã«ïŒâã¡ãã«ããªâïŒâãã¢ãŸãªã³ã®ïŒ
mlãå ããåŸãããæ··åç©ã20æéãã€ãããšé
æµãããå·åŽåŸãåå¿æ··åç©ã10mlã®é ¢é žãšãã«
ã§åžéãã50âç空äžã«æ¿çž®ãããšãæ²¹ç¶ã®çæ
ç©ãåŸãããããã®çæç©ãé ¢é žãšãã«ã§ç²ç
ããåŸãããæ·¡é»è²ã®åºäœããéãã50âã§äžå€
ç空äžã«ä¹Ÿç¥ããããš390mgã®çæç©ãåŸãããã
C24H34N4SO5ã»H2OãšããŠã®å çŽ åæ èšç®å€ïŒïŒ£ïŒ56.68ïŒ ïŒ ïŒšïŒ7.13ïŒ ïŒ ïŒ®ïŒ
11.02ïŒ å®æž¬å€ïŒïŒ£ïŒ56.76ïŒ ïŒ ïŒšïŒ7.00ïŒ ïŒ ïŒ®ïŒ
11.07ïŒ å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒïŒïŒâãžãããâïŒâãã¢
ãŸã€ã«ïŒââãªãžã«ââãããªã³ ãšã¿ããŒã«ãšæ°Žã®ïŒïŒïŒæ··å溶液ã«N2âãïŒâ
ïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ãããã«ãâ
âãªãžã«ââãããªã³ã®406mgïŒïŒmmolïŒãå
ãããããã«ãããªãšãã«ã¢ãã³ã®0.28mlïŒïŒmm
olïŒãšïŒâã¯ãããšãã«ã€ãœããªâã·ã¢ããŒãã®
122mgãå ãããåŸãããæ··åç©ãããã¯ããã
18æééæµããã宀枩ã§äžã±æåŸåºäœãæ²æ®¿ãã
ãã®åºäœãæ°Žãšãšã¿ããŒã«ã§ç²ç ããæ°·å·äžã«å·
åŽãããçœè²ã®ç²æ«141mgãåŸãã
C24H34N4SO5ã»H2OãšããŠã®å çŽ åæå€ èšç®å€ïŒïŒ£ïŒ56.68ïŒ ïŒ ïŒšïŒ7.13ïŒ ïŒ ïŒ®ïŒ11.02ïŒ ïŒ ïŒ³ïŒ6.30ïŒ å®æž¬å€ïŒïŒ£ïŒ55.64ïŒ ïŒ ïŒšïŒ7.14ïŒ ïŒ ïŒ®ïŒ10.97ïŒ ïŒ ïŒ³ïŒ6.50ïŒ å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒâããªããžãã«ïŒââãªãž
ã«ââãããªã³ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³ïŒ405.5mgïŒ
ïŒmmolïŒãæ°Ž4.0mläžã«æº¶è§£ããããã®æº¶æ¶²ã«ã
ãªãšãã«ã¢ãã³ïŒ364mgïŒ3.6mmolïŒãå ããç¶ã
ãŠãšã¿ããŒã«6.0mlã«æº¶ãããïŒâã¯ããããªã
ãžã³ïŒ515.4mgïŒ1.5mmolïŒæº¶æ¶²ãã宀枩ã§10å以
äžãããŠãååããã¯ãããªãããã€ãããšæ»Žäž
ãããåŸãããåå¿æ··åç©ãããã¯ããã15æé
éæµããåŸãé ¢é žãšãã«ïŒããªãžã³ïŒé ¢é žïŒæ°Ž
10ïŒïŒïŒïŒïŒïŒã®ç³»ãçšããŠèå±€ã¯ãããã°ã©ã
ã€ãŒã«ãã€ãŠè©Šéšããããã®çµæã¯ãåå¿ãå šã
ã©å®çµããŠããããšã瀺ãããåå¿æ··åç©ãåŒã
ç¶ãïŒæééæµããæŸçœ®ããŠãç空äžã®æ¿çž®ãã
åŸãã³ãŒã³ã§æŽæµããåã³ç空äžã«æ¿çž®ãããé»
è²åºäœã®ç²çæç©ããã³ãŒã³ã§ç²ç ããé»ãã€è²
ã®åºäœããéããŠé€ãã次ã«ãã³ãŒã³ã§æŽæµããŠ
空æ°ä¹Ÿç¥ãããš760mgã®çæç©ãåŸãããããã®
çæç©ãã¡ã¿ããŒã«ïŒmlã«æº¶è§£ãã25Ã240cmã®
LHâ20ã«ã©ã ïŒã¡ã¿ããŒã«ç³»ïŒã«å±éãã20p.
s.i.ã®å§ã§40ç§ããå§ããŠïŒå20ç§æ¯ã«14ã15ml
ã¥ã€åå²ãããåå²ããåã ã¯ãé ¢é žãšãã«ïŒïœ
âãã¿ããŒã«ïŒé ¢é žïŒæ°ŽïŒïŒïŒïŒïŒïŒïŒã®ç³»ã®è
å±€ã¯ãããã°ã©ãã€ãŒãçšããŠè©Šéšããããåå²
éš42ã45ãåãããŠæ°Žã«æº¶è§£ãã40mlã®æ°Žã§æŽæµ
ããïŒmgã®Dowex50WâX2ïŒH+ïŒã«ã©ã ãéã
ãŠïŒmlæ¯ã«åå²ããŠåéãããåå²éšïŒã®æ¿çž®æ®
枣46.0mgã¯ãæšé¡ååç©ãäžãããNMRããŒã¿
ã¯ãæ±ããæ§é ãšäžèŽããããã¹ã¹ãã¯ãã«ã¯ã
M+ïŒ627mïŒïœ ïŒMWïŒ2TMSïŒãš612mïŒïœ ïŒM+
â15ïŒã瀺ããã å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒâãã³ãŸãã¢ãŸãªã«ïŒââ
ãªãžã«ââãããªã³ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³ïŒ405mgïŒïŒ
mmolïŒãæ°Ž4.0mläžã«æº¶è§£ããããªãšãã«ã¢ãã³
ïŒ364mgïŒ3.6mmolïŒãå ããåŸããšã¿ããŒã«6.0ml
ã«æº¶è§£ããïŒâã¯ãããã³ãŸãã¢ãŸãŒã«ïŒ254.5
mgïŒ1.5mmolïŒæº¶æ¶²ããã€ãããšæ»ŽäžããŠå ããã
åå¿æ··åç©ã宀枩ã§15åéããã¯ãããç¶ããŠ15
æéããã¯ãããªããéæµãããèå±€ã¯ãããã°
ã©ãã€ãŒã¯ãåå¿ãå šãã©å®çµããããšã瀺ãã
ããã«ïŒæééæµãç¶ãããåå¿æ··åç©ãå·åŽã
ããŸã§æŸçœ®ãããã®åŸç空äžã§æ¿çž®ãããç¶ããŠ
ãã³ãŒã³ã§ïŒåºŠæŽæµããåã³ç空äžã§æ¿çž®ããã
åŸãããç²çæç©ïŒ700mgïŒãã¡ã¿ããŒã«ç³»ãçš
ãã2.5Ã240cmã®LHâ620ã«ã©ã ã§ç²Ÿè£œãããå
å²éš42ã44ãæ¿çž®ïŒ201mgïŒããããã«äžèšå®æœ
äŸïŒã«ç€ºããåæ§ã®ææ³ã«ããã«ã©ã ã¯ãããã°
ã©ãã€ãŒã«ãã€ãŠç²Ÿè£œãããåå²éšïŒã®æ¿çž®æ®æž£
24.0mgã¯æšé¡ååç©ãäžããNMRããŒã¿ã¯æ±ã
ãæ§é ãšäžèŽããããã¹ã¹ãã¯ãã«ã¯ãM+ïŒ
565mïŒïœ ïŒ682ïŒM+ïŒ2TMSïŒâ117ïŒâ
COOSiMe3ïŒã瀺ããã å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒã¢ããã€ããã¡ãã«ïŒââãª
ãžã«ââãããªã³ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³ïŒ200mgïŒ
0.494mmolïŒãâã¡ãã«ã€ãœããªãŠã¬ã¢ãœã«ããš
ãŒãïŒ99mgïŒ0.519mmolïŒã2Nâæ°Žé žåãããªãŠ
ã 0.624mlS1.25mmolïŒãæ··åããæ°Žèžæ°æµŽäžã§ïŒ
æéå ç±ãããããã«å ç±ããåŸPHã7.0ã«èª¿æŽ
ãããçæç©ã®åé¢ã¯ãMeCl2ïŒMeOHïŒ
H2O60ïŒ40ïŒ10ã®ç³»ãçšããLHâ20ã®ã«ã©ã ã¯
ãããã°ã©ãã€ãŒã«ãã€ãŠè¡ãªã€ããåå²éš30â
38ïŒ148mgïŒã¯ãå床粟補ã®ããã«ãã©ãã·ãŠã¯ã
ããã°ã©ãã€ãŒã«äœ¿ããããåå²éš17ã24ïŒäžå
å²10mlïŒã¯æšé¡ååç©ïŒ90mgïŒãäžãããNMR
ããŒã¿ã¯æ±ããæ§é ãšäžèŽããã å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒâã€ãããšãã«ïŒââãªãž
ã«ââãããªã³  ãšãã«ã¢ã»ãã€ãããŒã æ°Ž20mläžã«ç¡æ°Žçé žã«ãªãŠã ïŒ4.37ïœïŒ31.6mm
olïŒã溶解ãããžãšãã«ãšãŒãã«ãå ããåŸããš
ãã«ã¢ã»ãã€ãããŒãå¡©é žå¡©ïŒ2.00ïœïŒ16.2mmolïŒ
ãå ãããåå¿æ··åç©ã10åéããã¯ãããæ°Žå±€
ã10mlã®ãžãšãã«ãšãŒãã«ã§æœåºããããšãŒãã«
å±€ãåããæ°Žã§æŽæµãããåŸããããšãŒãã«å±€ã
æšé¡ååç©ãå«ã¿ãçŽæ¥æ¬¡ã®æ®µéã«äœ¿çšãããã  N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«
ãããã«ãâN6âïŒïŒâã€ãããšãã«ïŒââãª
ãžã«ââãããªã³ ãšã¿ããŒã«10mlãšæ°ŽïŒmläžã«N2âãïŒâïŒïŒ³ïŒâ
ã«ã«ããã·âïŒâããšãã«ãããã«ãââãªãž
ã«ââãããªã³ïŒ400mgïŒ0.988mmolïŒã溶解ã
ããããã«ãäžèšã¹ãããã§åŸããšãŒãã«æº¶æ¶²
ãå ãããããã«ãšã¿ããŒã«ãå ããåå¿æ··åç©
ãäžå€ããã¯ãããããžãšãã«ãšãŒãã«ãšãšã¿ã
ãŒã«ãç空äžã«é€å»ããåŸãæ°Ž10mlãšãžãšãã«ãš
ãŒãã«20mlãå ãããæ°Žå±€ãåçµä¹Ÿç¥ïŒ649mgïŒ
ããåŸãäžèšå®æœäŸïŒã«èšããææ³ã§LHâ20ã®
ã«ã©ã ã¯ãããã°ã©ãã€ãŒãçšããŠçæç©ã®åé¢
ãšç²Ÿè£œãè¡ãªãã35mlæ¯ã«åå²ããåå²éš37ã39
ãããã«Dowexã®ã«ã©ã ã¯ãããã°ã©ãã€ãŒã
çšããŠç²Ÿè£œããç¶ããŠLHâ20ã®ã¯ãããã°ã©ã
ã€ãŒã«ãã€ãŠåé¢ããåå²éš29â30ããæšé¡åå
ç©ïŒ189mgïŒãåŸããNMRããŒã¿ã¯æ±ããæ§é
ãšäžèŽãããC23H34N4O5ãšããŠã®å çŽ åæå€ èšç®å€ïŒïŒ£ïŒ61.86ïŒ ïŒ ïŒšïŒ7.67ïŒ ïŒ ïŒ®ïŒ
12.55ïŒ å®æž¬å€ïŒïŒ£ïŒ62.54ïŒ ïŒ ïŒšïŒ7.85ïŒ ïŒ ïŒ®ïŒ
12.50ïŒ å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒã¡ãã«ã¢ããã·ã¢ãã€ããã¡
ãã«ïŒââãªãžã«ââãããªã³  N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«
ãããã«ãâN6âïŒã¡ãã«ããªã·ã¢ãã€ããã¡
ãã«ïŒââãªãžã«ââãããªã³ æ°ŽïŒmlããšã¿ããŒã«20mlãN2âãïŒâïŒïŒ³ïŒâã«
ã«ããã·âïŒâããšãã«ãããã«ãââãªãžã«
ââãããªã³ïŒ420mgïŒ1.04mmolïŒãSSâ²âãžã¡
ãã«ââã·ã¢ããžããªã€ããã«ãŒãããŒã
ïŒ300mgïŒ2.05mmolïŒãæ··åããåŸãããæŸãã 溶
液ã88âã§24æééæµãããã®åŸå®€æž©ã§1.5æ¥ã
ãã¯ããããåå¿æ··åç©ãç空äžã«æ¿çž®ããæ²¹ç¶
ç©è³ªïŒ825mgïŒãåŸãç¶ããŠããããäžèšå®æœäŸ
ïŒã§èšããææ³ã§LHâ20ã®ã«ã©ã ã¯ãããã°ã©
ãã€ãŒã«ä»ããã17mlæ¯ã«åå²ããåå²éš43â48
ãåãããŠæ¬¡ã®æ®µéã«äœ¿çšããããæ¿çž®ããã  N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«
ãããã«ãâN6âïŒã¡ãã«ã¢ããã·ã¢ãã€ãã
ã¡ãã«ïŒââãªãžã«âãããªã³ ã¹ãããã®çæç©ïŒ182mgïŒã«ãã¡ãã«ã¢ã
ã³ã®40ïŒ æ°Žæº¶æ¶²2.5mlãå ãããåŸãããæŸãã
溶液ã60âã§ïŒå€å ç±ããç空äžã§ä¹Ÿç¥ãããŸã§
æ¿çž®ããïŒ201mgïŒãåŸãããçæç©ã20c.c.ã®
Dowexã«ã©ã ã¯ãããã°ã©ãã€ãŒã«ä»ããæ°Ž100
mlãïŒïŒ ããªãžã³ïŒæ°Ž10mlÃïŒãïŒïŒ ã¢ã³ã¢ãã¢
æ°Ž25mlÃïŒã§æº¶åºãããããªãžã³æµåºã®åå²éšïŒ
âïŒãåãããŠãå°éã«ãŸã§æ¿çž®ããåçµä¹Ÿç¥ã
ãïŒ44.1mgïŒããã®çæç©ããäžèšå®æœäŸïŒã§èš
ããææ³ã§ãLHâ20ã®ã«ã©ã ã¯ãããã°ã©ãã€
ãŒã«ä»ãã35mlæ¯ã«åå²ãåéãããåå²éš43â
50ãåãããŠæ¿çž®ããç¶ããŠæ°Žã«æº¶è§£ãåçµä¹Ÿç¥
ãããšæšé¡ååç©ïŒ24.5mgïŒãåŸãã
C24H34N6O5ãšããŠã®å çŽ åæå€ïŒ èšç®å€ïŒïŒ£ïŒ59.24ïŒ ïŒïŒšïŒ7.04ïŒ ïŒïŒ®ïŒ17.24
ïŒ å®æž¬å€ïŒïŒ£ïŒ58.7 ïŒ ïŒïŒšïŒ6.81ïŒ ïŒïŒ®ïŒ17.08
ïŒ å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒâã¢ããâ1HâïŒïŒïŒïŒïŒ
âããªã¢ãŸãªã«ïŒââãªãžã«ââãããªã³ ãã®ååç©ã¯ã90ïŒ ãšã¿ããŒã«ïŒ20mlïŒãçšã
ã以å€ã¯ãN2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâã
ãšãã«ãããã«ãâN6âïŒã¡ãã«ã¢ããã·ã¢ãã€
ããã¡ãã«ïŒââãªãžã«ââãããªã³ã®åæ
ãšåæ§ã®ææ³ã§åæããã290mgã®N2âãïŒâ
ïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ãããã«ãâN6
âïŒã¡ãã«ããªã·ã¢ãã€ããã¡ãã«ïŒââãªãžã«
ââãããªã³ãšã95ïŒ ããã©ãžã³0.5mlããïŒ
ïŒ ããªãžã³æ°Žæº¶æ¶²ãçšããDowex50Wâ2Xã®ã¯
ãããã°ã©ãã€ãŒããä»ãããšã«ããã21.0mgã®
N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ãã
ãã«ãâN6âïŒïŒâã¢ããâ1HâïŒïŒïŒïŒïŒâã
ãªã¢ãŸãªã«ïŒââãªãžã«ââãããªã³ãåçµ
也ç¥ããçœè²åºäœãšããŠåŸããé«å解èœãã¹
ïŒFABïŒã¯469mïŒïœ ã瀺ããããã¯æ±ããçæ
ç©ã®ååã€ãªã³ïŒM+487ïŒããæ°ŽïŒ18ïŒã倱ã€ã
ããšã瀺ããŠããã
ã«èšãåå¿å³ã«åŸã€ãŠéæãããã  åè¿°ããåå¿ã§çšããããè©Šè¬ã¯ãããšãã°ã
ã³ãŸã€ã«ã¯ããªããã·ã¢ãã²ã³ãããããã¡ãã«
ã€ãœã·ã¢ããŒãåã³ãã³ãŒã³ã¹ã«ããã«ã¯ããªã
ãå«ãã§ãããèªå°äœåæåå¿ã¯äž»ãšããŠããªãš
ãã«ã¢ãã³ã®åŠãéãããã³æ§å¡©åºã®ååšäž
DMFã®åŠãäžæŽ»æ§æº¶åªäžã§è¡ãªããããä»ã®å
å¿æ¡ä»¶ã¯ä»¥äžã«èšãããŠããå®éšäŸã®äžã§èšèŒã
ããŠããã ããã§äœ¿ãããåºçºç©è³ªã¯ãN2âãïŒâïŒïŒ³ïŒâ
ã«ã«ããã·âïŒâããšãã«ãããã«ãââã¢ã«
ã®ãã«ââãããªã³ã§ãããããã¯æ¬§å·å ¬éç¹
蚱第0012401å·ã®å®æœäŸ121ã«åŸã€ãŠåæãããã
ãŸããåæçµéã®å šäœãéããŠãã¢ããé žã®èªå°
äœãå©çšããããšã«ãã€ãŠãæ¬çºæã®ååç©çŸ€ã®
ããã€ããåæããããšãå¯èœã§ãããããšã
ã°ãαâã«ã«ããã³ãžã«ãªãã·âÏâãããã¢ã«
ã®ãã³ããããçš®ã®ã¢ããé žãšã¹ãã«ãšçž®åãã
ç¶ããŠéå çã«ïŒâãªããã¢ã«ã«ãã³é žãšã¢ã«ã
ã«åããä¿è·åºãé€å»ãããšãæ§é åŒã®G1ã
ïŒNNO2ã®ååç©ãåŸãããšãã§ããã ç¶ãå®æœäŸã§ã¯ãããã«ãæ§é åŒã®ååç©ã
åæããã®ã«çšããããè©Šè¬ãšåæçµè·¯ãèšãã
ãŠããããããã¯æ¬çºæã®å žåçãªâå¶éçãªã
ã®ã§ã¯ãâå®æœäŸãšãªããã®ã§ããã å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒïŒïŒâãžãããâïŒâãã¢
ãŸã€ã«ïŒââãªãžã«ââãããªã³ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³ïŒ406mgãïŒ
mmolïŒãã¡ã¿ããŒã«10mlãšæ°ŽïŒmläžã«æº¶è§£ããã
ãã®æº¶æ¶²ã«ïŒâã¡ãã«ããªâïŒâãã¢ãŸãªã³ã®ïŒ
mlãå ããåŸãããæ··åç©ã20æéãã€ãããšé
æµãããå·åŽåŸãåå¿æ··åç©ã10mlã®é ¢é žãšãã«
ã§åžéãã50âç空äžã«æ¿çž®ãããšãæ²¹ç¶ã®çæ
ç©ãåŸãããããã®çæç©ãé ¢é žãšãã«ã§ç²ç
ããåŸãããæ·¡é»è²ã®åºäœããéãã50âã§äžå€
ç空äžã«ä¹Ÿç¥ããããš390mgã®çæç©ãåŸãããã
C24H34N4SO5ã»H2OãšããŠã®å çŽ åæ èšç®å€ïŒïŒ£ïŒ56.68ïŒ ïŒ ïŒšïŒ7.13ïŒ ïŒ ïŒ®ïŒ
11.02ïŒ å®æž¬å€ïŒïŒ£ïŒ56.76ïŒ ïŒ ïŒšïŒ7.00ïŒ ïŒ ïŒ®ïŒ
11.07ïŒ å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒïŒïŒâãžãããâïŒâãã¢
ãŸã€ã«ïŒââãªãžã«ââãããªã³ ãšã¿ããŒã«ãšæ°Žã®ïŒïŒïŒæ··å溶液ã«N2âãïŒâ
ïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ãããã«ãâ
âãªãžã«ââãããªã³ã®406mgïŒïŒmmolïŒãå
ãããããã«ãããªãšãã«ã¢ãã³ã®0.28mlïŒïŒmm
olïŒãšïŒâã¯ãããšãã«ã€ãœããªâã·ã¢ããŒãã®
122mgãå ãããåŸãããæ··åç©ãããã¯ããã
18æééæµããã宀枩ã§äžã±æåŸåºäœãæ²æ®¿ãã
ãã®åºäœãæ°Žãšãšã¿ããŒã«ã§ç²ç ããæ°·å·äžã«å·
åŽãããçœè²ã®ç²æ«141mgãåŸãã
C24H34N4SO5ã»H2OãšããŠã®å çŽ åæå€ èšç®å€ïŒïŒ£ïŒ56.68ïŒ ïŒ ïŒšïŒ7.13ïŒ ïŒ ïŒ®ïŒ11.02ïŒ ïŒ ïŒ³ïŒ6.30ïŒ å®æž¬å€ïŒïŒ£ïŒ55.64ïŒ ïŒ ïŒšïŒ7.14ïŒ ïŒ ïŒ®ïŒ10.97ïŒ ïŒ ïŒ³ïŒ6.50ïŒ å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒâããªããžãã«ïŒââãªãž
ã«ââãããªã³ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³ïŒ405.5mgïŒ
ïŒmmolïŒãæ°Ž4.0mläžã«æº¶è§£ããããã®æº¶æ¶²ã«ã
ãªãšãã«ã¢ãã³ïŒ364mgïŒ3.6mmolïŒãå ããç¶ã
ãŠãšã¿ããŒã«6.0mlã«æº¶ãããïŒâã¯ããããªã
ãžã³ïŒ515.4mgïŒ1.5mmolïŒæº¶æ¶²ãã宀枩ã§10å以
äžãããŠãååããã¯ãããªãããã€ãããšæ»Žäž
ãããåŸãããåå¿æ··åç©ãããã¯ããã15æé
éæµããåŸãé ¢é žãšãã«ïŒããªãžã³ïŒé ¢é žïŒæ°Ž
10ïŒïŒïŒïŒïŒïŒã®ç³»ãçšããŠèå±€ã¯ãããã°ã©ã
ã€ãŒã«ãã€ãŠè©Šéšããããã®çµæã¯ãåå¿ãå šã
ã©å®çµããŠããããšã瀺ãããåå¿æ··åç©ãåŒã
ç¶ãïŒæééæµããæŸçœ®ããŠãç空äžã®æ¿çž®ãã
åŸãã³ãŒã³ã§æŽæµããåã³ç空äžã«æ¿çž®ãããé»
è²åºäœã®ç²çæç©ããã³ãŒã³ã§ç²ç ããé»ãã€è²
ã®åºäœããéããŠé€ãã次ã«ãã³ãŒã³ã§æŽæµããŠ
空æ°ä¹Ÿç¥ãããš760mgã®çæç©ãåŸãããããã®
çæç©ãã¡ã¿ããŒã«ïŒmlã«æº¶è§£ãã25Ã240cmã®
LHâ20ã«ã©ã ïŒã¡ã¿ããŒã«ç³»ïŒã«å±éãã20p.
s.i.ã®å§ã§40ç§ããå§ããŠïŒå20ç§æ¯ã«14ã15ml
ã¥ã€åå²ãããåå²ããåã ã¯ãé ¢é žãšãã«ïŒïœ
âãã¿ããŒã«ïŒé ¢é žïŒæ°ŽïŒïŒïŒïŒïŒïŒïŒã®ç³»ã®è
å±€ã¯ãããã°ã©ãã€ãŒãçšããŠè©Šéšããããåå²
éš42ã45ãåãããŠæ°Žã«æº¶è§£ãã40mlã®æ°Žã§æŽæµ
ããïŒmgã®Dowex50WâX2ïŒH+ïŒã«ã©ã ãéã
ãŠïŒmlæ¯ã«åå²ããŠåéãããåå²éšïŒã®æ¿çž®æ®
枣46.0mgã¯ãæšé¡ååç©ãäžãããNMRããŒã¿
ã¯ãæ±ããæ§é ãšäžèŽããããã¹ã¹ãã¯ãã«ã¯ã
M+ïŒ627mïŒïœ ïŒMWïŒ2TMSïŒãš612mïŒïœ ïŒM+
â15ïŒã瀺ããã å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒâãã³ãŸãã¢ãŸãªã«ïŒââ
ãªãžã«ââãããªã³ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³ïŒ405mgïŒïŒ
mmolïŒãæ°Ž4.0mläžã«æº¶è§£ããããªãšãã«ã¢ãã³
ïŒ364mgïŒ3.6mmolïŒãå ããåŸããšã¿ããŒã«6.0ml
ã«æº¶è§£ããïŒâã¯ãããã³ãŸãã¢ãŸãŒã«ïŒ254.5
mgïŒ1.5mmolïŒæº¶æ¶²ããã€ãããšæ»ŽäžããŠå ããã
åå¿æ··åç©ã宀枩ã§15åéããã¯ãããç¶ããŠ15
æéããã¯ãããªããéæµãããèå±€ã¯ãããã°
ã©ãã€ãŒã¯ãåå¿ãå šãã©å®çµããããšã瀺ãã
ããã«ïŒæééæµãç¶ãããåå¿æ··åç©ãå·åŽã
ããŸã§æŸçœ®ãããã®åŸç空äžã§æ¿çž®ãããç¶ããŠ
ãã³ãŒã³ã§ïŒåºŠæŽæµããåã³ç空äžã§æ¿çž®ããã
åŸãããç²çæç©ïŒ700mgïŒãã¡ã¿ããŒã«ç³»ãçš
ãã2.5Ã240cmã®LHâ620ã«ã©ã ã§ç²Ÿè£œãããå
å²éš42ã44ãæ¿çž®ïŒ201mgïŒããããã«äžèšå®æœ
äŸïŒã«ç€ºããåæ§ã®ææ³ã«ããã«ã©ã ã¯ãããã°
ã©ãã€ãŒã«ãã€ãŠç²Ÿè£œãããåå²éšïŒã®æ¿çž®æ®æž£
24.0mgã¯æšé¡ååç©ãäžããNMRããŒã¿ã¯æ±ã
ãæ§é ãšäžèŽããããã¹ã¹ãã¯ãã«ã¯ãM+ïŒ
565mïŒïœ ïŒ682ïŒM+ïŒ2TMSïŒâ117ïŒâ
COOSiMe3ïŒã瀺ããã å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒã¢ããã€ããã¡ãã«ïŒââãª
ãžã«ââãããªã³ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãââãªãžã«ââãããªã³ïŒ200mgïŒ
0.494mmolïŒãâã¡ãã«ã€ãœããªãŠã¬ã¢ãœã«ããš
ãŒãïŒ99mgïŒ0.519mmolïŒã2Nâæ°Žé žåãããªãŠ
ã 0.624mlS1.25mmolïŒãæ··åããæ°Žèžæ°æµŽäžã§ïŒ
æéå ç±ãããããã«å ç±ããåŸPHã7.0ã«èª¿æŽ
ãããçæç©ã®åé¢ã¯ãMeCl2ïŒMeOHïŒ
H2O60ïŒ40ïŒ10ã®ç³»ãçšããLHâ20ã®ã«ã©ã ã¯
ãããã°ã©ãã€ãŒã«ãã€ãŠè¡ãªã€ããåå²éš30â
38ïŒ148mgïŒã¯ãå床粟補ã®ããã«ãã©ãã·ãŠã¯ã
ããã°ã©ãã€ãŒã«äœ¿ããããåå²éš17ã24ïŒäžå
å²10mlïŒã¯æšé¡ååç©ïŒ90mgïŒãäžãããNMR
ããŒã¿ã¯æ±ããæ§é ãšäžèŽããã å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒâã€ãããšãã«ïŒââãªãž
ã«ââãããªã³  ãšãã«ã¢ã»ãã€ãããŒã æ°Ž20mläžã«ç¡æ°Žçé žã«ãªãŠã ïŒ4.37ïœïŒ31.6mm
olïŒã溶解ãããžãšãã«ãšãŒãã«ãå ããåŸããš
ãã«ã¢ã»ãã€ãããŒãå¡©é žå¡©ïŒ2.00ïœïŒ16.2mmolïŒ
ãå ãããåå¿æ··åç©ã10åéããã¯ãããæ°Žå±€
ã10mlã®ãžãšãã«ãšãŒãã«ã§æœåºããããšãŒãã«
å±€ãåããæ°Žã§æŽæµãããåŸããããšãŒãã«å±€ã
æšé¡ååç©ãå«ã¿ãçŽæ¥æ¬¡ã®æ®µéã«äœ¿çšãããã  N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«
ãããã«ãâN6âïŒïŒâã€ãããšãã«ïŒââãª
ãžã«ââãããªã³ ãšã¿ããŒã«10mlãšæ°ŽïŒmläžã«N2âãïŒâïŒïŒ³ïŒâ
ã«ã«ããã·âïŒâããšãã«ãããã«ãââãªãž
ã«ââãããªã³ïŒ400mgïŒ0.988mmolïŒã溶解ã
ããããã«ãäžèšã¹ãããã§åŸããšãŒãã«æº¶æ¶²
ãå ãããããã«ãšã¿ããŒã«ãå ããåå¿æ··åç©
ãäžå€ããã¯ãããããžãšãã«ãšãŒãã«ãšãšã¿ã
ãŒã«ãç空äžã«é€å»ããåŸãæ°Ž10mlãšãžãšãã«ãš
ãŒãã«20mlãå ãããæ°Žå±€ãåçµä¹Ÿç¥ïŒ649mgïŒ
ããåŸãäžèšå®æœäŸïŒã«èšããææ³ã§LHâ20ã®
ã«ã©ã ã¯ãããã°ã©ãã€ãŒãçšããŠçæç©ã®åé¢
ãšç²Ÿè£œãè¡ãªãã35mlæ¯ã«åå²ããåå²éš37ã39
ãããã«Dowexã®ã«ã©ã ã¯ãããã°ã©ãã€ãŒã
çšããŠç²Ÿè£œããç¶ããŠLHâ20ã®ã¯ãããã°ã©ã
ã€ãŒã«ãã€ãŠåé¢ããåå²éš29â30ããæšé¡åå
ç©ïŒ189mgïŒãåŸããNMRããŒã¿ã¯æ±ããæ§é
ãšäžèŽãããC23H34N4O5ãšããŠã®å çŽ åæå€ èšç®å€ïŒïŒ£ïŒ61.86ïŒ ïŒ ïŒšïŒ7.67ïŒ ïŒ ïŒ®ïŒ
12.55ïŒ å®æž¬å€ïŒïŒ£ïŒ62.54ïŒ ïŒ ïŒšïŒ7.85ïŒ ïŒ ïŒ®ïŒ
12.50ïŒ å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒã¡ãã«ã¢ããã·ã¢ãã€ããã¡
ãã«ïŒââãªãžã«ââãããªã³  N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«
ãããã«ãâN6âïŒã¡ãã«ããªã·ã¢ãã€ããã¡
ãã«ïŒââãªãžã«ââãããªã³ æ°ŽïŒmlããšã¿ããŒã«20mlãN2âãïŒâïŒïŒ³ïŒâã«
ã«ããã·âïŒâããšãã«ãããã«ãââãªãžã«
ââãããªã³ïŒ420mgïŒ1.04mmolïŒãSSâ²âãžã¡
ãã«ââã·ã¢ããžããªã€ããã«ãŒãããŒã
ïŒ300mgïŒ2.05mmolïŒãæ··åããåŸãããæŸãã 溶
液ã88âã§24æééæµãããã®åŸå®€æž©ã§1.5æ¥ã
ãã¯ããããåå¿æ··åç©ãç空äžã«æ¿çž®ããæ²¹ç¶
ç©è³ªïŒ825mgïŒãåŸãç¶ããŠããããäžèšå®æœäŸ
ïŒã§èšããææ³ã§LHâ20ã®ã«ã©ã ã¯ãããã°ã©
ãã€ãŒã«ä»ããã17mlæ¯ã«åå²ããåå²éš43â48
ãåãããŠæ¬¡ã®æ®µéã«äœ¿çšããããæ¿çž®ããã  N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«
ãããã«ãâN6âïŒã¡ãã«ã¢ããã·ã¢ãã€ãã
ã¡ãã«ïŒââãªãžã«âãããªã³ ã¹ãããã®çæç©ïŒ182mgïŒã«ãã¡ãã«ã¢ã
ã³ã®40ïŒ æ°Žæº¶æ¶²2.5mlãå ãããåŸãããæŸãã
溶液ã60âã§ïŒå€å ç±ããç空äžã§ä¹Ÿç¥ãããŸã§
æ¿çž®ããïŒ201mgïŒãåŸãããçæç©ã20c.c.ã®
Dowexã«ã©ã ã¯ãããã°ã©ãã€ãŒã«ä»ããæ°Ž100
mlãïŒïŒ ããªãžã³ïŒæ°Ž10mlÃïŒãïŒïŒ ã¢ã³ã¢ãã¢
æ°Ž25mlÃïŒã§æº¶åºãããããªãžã³æµåºã®åå²éšïŒ
âïŒãåãããŠãå°éã«ãŸã§æ¿çž®ããåçµä¹Ÿç¥ã
ãïŒ44.1mgïŒããã®çæç©ããäžèšå®æœäŸïŒã§èš
ããææ³ã§ãLHâ20ã®ã«ã©ã ã¯ãããã°ã©ãã€
ãŒã«ä»ãã35mlæ¯ã«åå²ãåéãããåå²éš43â
50ãåãããŠæ¿çž®ããç¶ããŠæ°Žã«æº¶è§£ãåçµä¹Ÿç¥
ãããšæšé¡ååç©ïŒ24.5mgïŒãåŸãã
C24H34N6O5ãšããŠã®å çŽ åæå€ïŒ èšç®å€ïŒïŒ£ïŒ59.24ïŒ ïŒïŒšïŒ7.04ïŒ ïŒïŒ®ïŒ17.24
ïŒ å®æž¬å€ïŒïŒ£ïŒ58.7 ïŒ ïŒïŒšïŒ6.81ïŒ ïŒïŒ®ïŒ17.08
ïŒ å®æœäŸ ïŒ N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ãâN6âïŒïŒâã¢ããâ1HâïŒïŒïŒïŒïŒ
âããªã¢ãŸãªã«ïŒââãªãžã«ââãããªã³ ãã®ååç©ã¯ã90ïŒ ãšã¿ããŒã«ïŒ20mlïŒãçšã
ã以å€ã¯ãN2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâã
ãšãã«ãããã«ãâN6âïŒã¡ãã«ã¢ããã·ã¢ãã€
ããã¡ãã«ïŒââãªãžã«ââãããªã³ã®åæ
ãšåæ§ã®ææ³ã§åæããã290mgã®N2âãïŒâ
ïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ãããã«ãâN6
âïŒã¡ãã«ããªã·ã¢ãã€ããã¡ãã«ïŒââãªãžã«
ââãããªã³ãšã95ïŒ ããã©ãžã³0.5mlããïŒ
ïŒ ããªãžã³æ°Žæº¶æ¶²ãçšããDowex50Wâ2Xã®ã¯
ãããã°ã©ãã€ãŒããä»ãããšã«ããã21.0mgã®
N2âãïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ãã
ãã«ãâN6âïŒïŒâã¢ããâ1HâïŒïŒïŒïŒïŒâã
ãªã¢ãŸãªã«ïŒââãªãžã«ââãããªã³ãåçµ
也ç¥ããçœè²åºäœãšããŠåŸããé«å解èœãã¹
ïŒFABïŒã¯469mïŒïœ ã瀺ããããã¯æ±ããçæ
ç©ã®ååã€ãªã³ïŒM+487ïŒããæ°ŽïŒ18ïŒã倱ã€ã
ããšã瀺ããŠããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ¬¡ã®æ§é åŒ ïŒ»åŒäžã ã¯æ°ŽçŽ ã R1ã¯ããšãã«äœçŽã¢ã«ãã«ã R2ã¯âïŒCH2ïŒ4âNHâ ïŒïŒ§ã¯ïŒïŒïŒãžãããâïŒâãã¢ãŸãªã«ãïŒâ
ããªããžãã«ãïŒâãã³ãŸãã¢ãŸãªã«ãïŒâã¢ã
ãâ1HâïŒïŒïŒïŒïŒâããªã¢ãŸãªâïŒâã€ã«ã
ãŸãã¯ãåŒã ïŒG1ã¯NHãŸãã¯ïŒ®âCNãG2ã¯NH2ãäœçŽã¢
ã«ãã«ã¢ãããŸãã¯äœçŽã¢ã«ãã«ïŒïŒã ãåŒãã¯ãåŒã ã瀺ã ãããªãååç©ãåã³è©²ååç©ã®è¬åŠçã«èš±å®¹ã
ããå¡©ã ïŒ äžèšã®çŸ€ïŒ N2âïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ïŒœâN6âïŒïŒïŒïŒâãžãããâïŒâãã¢ãŸ
ã€ã«ïŒââãªãžã«ââãããªã³ïŒ N2âïŒâïŒïŒ³ïŒâã«ã«ããã·âïŒâããšãã«ã
ããã«ïŒœâN6âïŒïŒâããªããžãã«ïŒââãªãžã«
ââãããªã³ïŒ ã®ïŒå¡ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31934181A | 1981-11-09 | 1981-11-09 | |
US319341 | 1981-11-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5888345A JPS5888345A (ja) | 1983-05-26 |
JPH0352477B2 true JPH0352477B2 (ja) | 1991-08-12 |
Family
ID=23241843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57195419A Granted JPS5888345A (ja) | 1981-11-09 | 1982-11-09 | âã«ã«ããã·ã¡ãã«ïŒã¢ããžãïŒãªãžã«âãããªã³æé«è¡å§å€ |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0079522B1 (ja) |
JP (1) | JPS5888345A (ja) |
DE (1) | DE3271043D1 (ja) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3246503A1 (de) * | 1982-12-16 | 1984-06-20 | Hoechst Ag, 6230 Frankfurt | Derivate der cis, endo-2-azabicyclo-(5.3.0)-decan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung |
DE3408923A1 (de) * | 1984-03-12 | 1985-09-26 | Hoechst Ag, 6230 Frankfurt | Carboxyalkyldipeptidderivate, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
DE3436569A1 (de) * | 1984-10-05 | 1986-04-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Aminosaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen |
HU192914B (en) * | 1985-02-11 | 1987-07-28 | Richter Gedeon Vegyeszet | Process for producing new 3-/substituted amino/-5-phenyl-2/3h/-furanone derivatives and pharmaceutically acceptable salts |
CN86101850A (zh) * | 1985-03-22 | 1987-02-04 | 森åŸå æ¯(çŸåœ)æéå ¬åž | NïŒnâ²-äºç·åºèåºäºèœçå¶é æ¹æ³äžçšé |
US4762821A (en) * | 1985-03-22 | 1988-08-09 | Syntex (U.S.A.) Inc. | N',N"-dialkylguanidino dipeptides |
US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
EP0566157A1 (en) | 1986-06-20 | 1993-10-20 | Schering Corporation | Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
US4749688A (en) * | 1986-06-20 | 1988-06-07 | Schering Corporation | Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension |
EP0254032A3 (en) * | 1986-06-20 | 1990-09-05 | Schering Corporation | Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
US5262436A (en) * | 1987-03-27 | 1993-11-16 | Schering Corporation | Acylamino acid antihypertensives in the treatment of congestive heart failure |
ZA902661B (en) * | 1989-04-10 | 1991-01-30 | Schering Corp | Mercapto-acyl amino acids |
US5110799A (en) * | 1989-07-28 | 1992-05-05 | Merck & Co., Inc. | Antiherpetic agents |
US5169932A (en) * | 1989-10-30 | 1992-12-08 | The Salk Institute For Biological Studies | Gnrh analogs |
US5352796A (en) * | 1989-10-30 | 1994-10-04 | The Salk Institute For Biological Studies | Amino acids useful in making GnRH analogs |
CA2069112A1 (en) * | 1989-11-21 | 1991-05-22 | Bernard R. Neustadt | Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
US5075302A (en) * | 1990-03-09 | 1991-12-24 | Schering Corporation | Mercaptoacyl aminolactam endopeptidase inhibitors |
US5173506A (en) * | 1990-08-16 | 1992-12-22 | Schering Corporation | N-(mercaptoalkyl)ureas and carbamates |
TW197945B (ja) * | 1990-11-27 | 1993-01-11 | Hoechst Ag | |
US5744450A (en) | 1991-03-14 | 1998-04-28 | The Salk Institute For Biological Studies | GnRH analogs |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
EP0278530A3 (de) * | 1980-08-30 | 1989-08-02 | Hoechst Aktiengesellschaft | AminosÀurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung |
US4296110A (en) * | 1980-10-28 | 1981-10-20 | E. I. Du Pont De Nemours And Company | Antihypertensive I-substituted cyclic lactam-2-carboxylic acids |
-
1982
- 1982-11-03 EP EP82110115A patent/EP0079522B1/en not_active Expired
- 1982-11-03 DE DE8282110115T patent/DE3271043D1/de not_active Expired
- 1982-11-09 JP JP57195419A patent/JPS5888345A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
DE3271043D1 (en) | 1986-06-12 |
EP0079522A1 (en) | 1983-05-25 |
JPS5888345A (ja) | 1983-05-26 |
EP0079522B1 (en) | 1986-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0352477B2 (ja) | ||
US5071837A (en) | Novel renin inhibiting peptides | |
US4668769A (en) | Oxa- and azahomocyclostatine polypeptides | |
FI112943B (fi) | Pyrimidinyylijohdannaisia ja niiden kÀyttö lÀÀkkeen valmistamiseksi interleukiini proteaasiaktiivisuuden inhiboimiseksi | |
EP0018549B1 (en) | Tetrahydroisoquinoline compounds, process for preparing them and pharmaceutical compositions containing them | |
JPH0629228B2 (ja) | ããããã·ã«ã¢ãã³èªå°äœ | |
JPH0720990B2 (ja) | ã¢ããé žãšã¹ãã«ããã³ã¢ããã¬ãã³æå¶å€ | |
JPS63253061A (ja) | ããªãŒã«ãããã¢ãŒãŒé»å®³å€ãšããŠã®ã¢ãªãŒã«ãªãã·ããã³ã¢ãªãŒã«ã¢ã·ã«ãªãã·ã¡ãã«ã±ãã³ | |
HU205352B (en) | Process for producing new imidazole derivatives and pharmaceutical compositions comprising same | |
KR100694528B1 (ko) | 2,5-ëì¥ì-ì¥ì¬ì¡žëŠ¬ë ì€ê°ì²Ž íí©ë¬Œì ì¬ì©í, í늰ëí늎 ë° ìŽì ìŒì ì ì¡°ë°©ë² | |
JPS5984869A (ja) | æé«è¡å§å€ãšããŠæçšãªïŒâïœâã¢ã«ãã«ã«ã«ããã·âãã³ãŸçž®åã©ã¯ã¿ã é¡ | |
US4680284A (en) | Modified phenylalanine peptidylaminodiols | |
HU204285B (en) | Process for producing renin-inhibiting polypeptides of small molecule mass and pharmaceutical compositions containing them | |
CA2126687A1 (en) | Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents | |
US5359086A (en) | Process for preparing alkyl-L-alanyl-L-proline derivatives | |
FR2577925A1 (fr) | Aminoalcanoylureido amino et imino acides et esters a substituant ester, a proprietes therapeutiques | |
FR2564845A1 (fr) | Mercaptocycloalkylcarbonyl et mercaptoarylcarbonyl dipeptides a action therapeutique | |
JPH058191B2 (ja) | ||
US4895834A (en) | Renin inhibitors III | |
JPH09505317A (ja) | æ°èŠã¢ããé žèªå°äœããããã®è£œé æ¹æ³åã³ãããã®ååç©ãå«æããå»è¬çµæç© | |
US5238923A (en) | Amino-substituted heterocycles as renin inhibitors | |
EP0081094A1 (en) | Substituted omega-amino-carboxymethyldipeptide antihypertensive agents | |
KR102360356B1 (ko) | íšì ìµì 륌 ìí ìíììŒí€ íí©ë¬Œ | |
EP0158947A2 (en) | Amino thiol dipeptides | |
FR2540867A1 (fr) | Halo-aminocetones utilisables comme intermediaires pour la preparation de peptides substitues |